Positions

Selected Publications

Academic Article

Year Title Altmetric
2019 Validation of the SymptoMScreen with performance-based or clinician-assessed outcomesMultiple Sclerosis and Related Disorders.  29:86-93. 2019
2019 A new way to estimate neurologic disease prevalence in the United States: Illustrated with MSNeurology.  92:469-480. 2019
2019 The prevalence of MS in the United States: A population-based estimate using health claims dataNeurology.  92:e1029-e1040. 2019
2019 Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trialLancet Neurology.  18:259-268. 2019
2019 Evolution of clinical trials in multiple sclerosisTherapeutic Advances in Neurological Disorders.  12. 2019
2019 Rasagiline for amyotrophic lateral sclerosis: A randomized, controlled trialMuscle and Nerve.  59:201-207. 2019
2019 A Randomized Internet-Based Pilot Feasibility and Planning Study of Cherry Extract and Diet Modification in Gout.JCR: Journal of Clinical Rheumatology2019
2019 Cortical Activation Elicited by Subthalamic Deep Brain Stimulation Predicts Postoperative Motor Side EffectsNeuromodulation2019
2019 Use of eHealth and mHealth technology by persons with multiple sclerosisMultiple Sclerosis and Related Disorders.  27:13-19. 2019
2018 High vigabatrin dosage is associated with lower risk of infantile spasms relapse among children with tuberous sclerosis complexEpilepsy Research.  148:1-7. 2018
2018 Medical Rehabilitation: Guidelines to Advance the Field With High-Impact Clinical TrialsArchives of Physical Medicine and Rehabilitation.  99:2637-2648. 2018
2018 Pseudobulbar affect prevalence and association with symptoms inmultiple sclerosisNeurology: Clinical Practice.  8:472-481. 2018
2018 Rationale and design of a single-blind, randomised controlled trial of exercise training for managing learning and memory impairment in persons with multiple sclerosisBMJ Open.  8. 2018
2018 Association of Concomitant Use of Cholinesterase Inhibitors or Memantine With Cognitive Decline in Alzheimer Clinical Trials: A Meta-analysis.Jama Network Open.  1:e184080. 2018
2018 Gender differences in prednisone adverse effects Survey result from the MG registryNeurology, Neuroimmunology and Neuroinflammation.  5. 2018
2018 Occupational Therapy Treatment to Improve Upper Extremity Function in Individuals with Early Systemic Sclerosis: A Pilot StudyArthritis Care and Research.  70:1653-1660. 2018
2018 Sun Safe Workplaces: Effect of an Occupational Skin Cancer Prevention Program on Employee Sun Safety PracticesJournal of Occupational and Environmental Medicine.  60:900-997. 2018
2018 Divergent effects of AKI to CKD models on inflammation and fibrosisAJP - Renal Physiology.  315:F1107-F1118. 2018
2018 Cannabidiol improves frequency and severity of seizures and reduces adverse events in an open-label add-on prospective studyEpilepsy and Behavior.  87:131-136. 2018
2018 The MSOAC approach to developing performance outcomes to measure and monitor multiple sclerosis disabilityMultiple Sclerosis.  24:1469-1484. 2018
2018 An introduction to Mendelian randomization with applications in neurologyMultiple Sclerosis and Related Disorders.  24:72-78. 2018
2018 Phase-III, randomized controlled trial of the behavioral intervention for increasing physical activity in multiple sclerosis: Project BIPAMSControlled Clinical Trials.  71:154-161. 2018
2018 Gender and quality of life in myasthenia gravis patients from the myasthenia gravis foundation of America registryMuscle and Nerve.  58:90-98. 2018
2018 Mortality in neuromyelitis optica is strongly associated with African ancestryNeurology, Neuroimmunology and Neuroinflammation.  5. 2018
2018 A contemporary profile of primary progressive multiple sclerosis participants from the NARCOMS RegistryMultiple Sclerosis.  24:951-962. 2018
2018 Histopathology of thymectomy specimens from the MGTX-trial: Entropy analysis as strategy to quantify spatial heterogeneity of lymphoid follicle and fat distributionPLoS ONE.  13. 2018
2018 A survey of dietary characteristics in a large population of people with multiple sclerosisMultiple Sclerosis and Related Disorders.  22:12-18. 2018
2018 Predictive validity of NEDA in the 16- and 21-year follow-up from the pivotal trial of interferon beta-1bMultiple Sclerosis2018
2018 Results of a Randomized Trial on an Intervention Promoting Adoption of Occupational Sun Protection PoliciesAmerican Journal of Health Promotion.  32:1042-1053. 2018
2018 Factors associated with excessive sitting time in multiple sclerosisMultiple Sclerosis and Related Disorders.  21:71-77. 2018
2018 Declining Financial Capacity in Mild Cognitive Impairment: A Six-Year Longitudinal StudyArchives of Clinical Neuropsychology.  34:152-161. 2018
2018 Defining standard enzymatic dissociation methods for individual brains and spinal cords in EAENeurology, Neuroimmunology and Neuroinflammation.  5. 2018
2018 Phase II Randomized Controlled Trial of Constraint-Induced Movement Therapy in Multiple Sclerosis. Part 1: Effects on Real-World FunctionNeurorehabilitation and Neural Repair.  32:223-232. 2018
2018 Understanding and preventing loss to follow-up: Experiences from the spinal cord injury model systemsTopics in Spinal Cord Injury Rehabilitation.  24:97-109. 2018
2018 Accuracy of blood pressure measurement devices in pregnancy: A systematic review of validation studiesHypertension.  71:326-335. 2018
2018 Treatment satisfaction and bothersome bladder, bowel, sexual symptoms in multiple sclerosisMultiple Sclerosis and Related Disorders.  20:16-21. 2018
2018 Diet quality is associated with disability and symptom severity in multiple sclerosis.Neurology.  90:e1-e11. 2018
2018 Cannabidiol improves frequency and severity of seizures and reduces adverse events in an open-label add-on prospective study Pongkiat Kankirawatana, Dr Rani Singh, Professor David G Standaert, Dr Yuliang Liu, Dr Leon Dure, Dr Jennifer DeWollfe, Professor Gary Cutter, Dr Tyler Gaston, Dr Ashley Thomas, Professor E. Martina Bebin, Dr. Lawrence Ver HoefEpilepsy and Behavior.  (in press). 2018
2018 Clinical trials in multiple sclerosis: milestonesTherapeutic Advances in Neurological Disorders.  11. 2018
2018 DuraGraft vascular conduit preservation solution in patients undergoing coronary artery bypass grafting: rationale and design of a within-patient randomised multicentre trial.Open Heart.  5:e000780. 2018
2018 Implementation of Occupational Sun Safety at a 2-Year Follow-Up in a Randomized Trial: Comparison of Sun Safe Workplaces Policy Intervention to Attention ControlAmerican Journal of Health Promotion2018
2018 Learning from the past: Reflections on recently completed myasthenia gravis trialsAnnals of the New York Academy of Sciences.  1412:5-13. 2018
2018 National estimates of self-reported sitting time in adults with multiple sclerosis.Multiple Sclerosis Journal - Experimental, Translational and Clinical.  4:2055217318754368. 2018
2018 Neurofibromatosis Clinical Trial ConsortiumJournal of Child Neurology.  33:82-91. 2018
2018 Short-term disability progression in two multiethnic multiple sclerosis centers in the treatment eraTherapeutic Advances in Neurological Disorders.  11. 2018
2017 A Randomized Trial of an Advanced Sun Safety Intervention for Vacationers at 41 North American ResortsJournal of Health Communication.  22:951-963. 2017
2017 Pedestrian safety in patients with Parkinson's disease: A case-control studyMovement Disorders.  32:1748-1755. 2017
2017 Presentation and diagnosis of tuberous sclerosis complex in infantsPediatrics.  140. 2017
2017 Long-term follow-up of a randomized study of combination interferon and glatiramer acetate in multiple sclerosis: Efficacy and safety results up to 7 yearsMultiple Sclerosis and Related Disorders.  18:95-102. 2017
2017 Challenging Assumptions About African American Participation in Alzheimer Disease TrialsAmerican Journal of Geriatric Psychiatry.  25:1150-1159. 2017
2017 Clinical trial design for progressive MS trialsMultiple Sclerosis.  23:1642-1648. 2017
2017 Utility of the Autism Observation Scale for Infants in Early Identification of Autism in Tuberous Sclerosis ComplexPediatric Neurology.  75:80-86. 2017
2017 Author response: High hypothetical interest in physician-assisted death in multiple sclerosisNeurology.  89:1429-1430. 2017
2017 Evaluating risk factors for chronic kidney disease in pediatric patients with sickle cell anemiaPediatric Nephrology.  32:1565-1573. 2017
2017 Interactions between cannabidiol and commonly used antiepileptic drugsEpilepsia.  58:1586-1592. 2017
2017 Laquinimod has no effects on brain volume or cellular CNS composition in the F1 3xTg-AD/C3H mouse model of Alzheimer's diseaseJournal of Neuroimmunology.  309:100-110. 2017
2017 Erratum to: Assessing the feasibility of the Effectiveness of Discontinuing Bisphosphonates trial: a pilot study (Osteoporosis International, (2017), 28, 8, (2495-2503), 10.1007/s00198-017-4073-5)Osteoporosis International.  28:2505. 2017
2017 Perspectives on marijuana use and effectiveness: A survey of NARCOMS participantsNeurology: Clinical Practice.  7:333-343. 2017
2017 Dysregulation of 14-3-3 proteins in neurodegenerative diseases with Lewy body or Alzheimer pathologyAnnals of Clinical and Translational Neurology.  4:466-477. 2017
2017 Which symptoms contribute the most to patients' perception of health in multiple sclerosis?Multiple Sclerosis Journal - Experimental, Translational and Clinical.  3:2055217317728301. 2017
2017 Comparative effectiveness of delayed-release dimethyl fumarate versus glatiramer acetate in multiple sclerosis patients: Results of a matching-adjusted indirect comparisonJournal of Comparative Effectiveness Research.  6:313-323. 2017
2017 Effect of an intervention on observed sun protection by vacationers in a randomized controlled trial at North American resortsPreventive Medicine.  99:29-36. 2017
2017 Assessing the feasibility of the Effectiveness of Discontinuing Bisphosphonates trial: a pilot studyOsteoporosis International.  1-9. 2017
2017 Employment and absenteeism in working-age persons with multiple sclerosisJournal of Medical Economics (JME).  20:493-502. 2017
2017 Publication outcomes of abstracts from the American Society of Hematology Annual MeetingAmerican Journal of Hematology.  92:E81-E83. 2017
2017 The Virtual Short Physical Performance Battery: Psychometric Properties and Validation in Older Adults With Multiple Sclerosis.Journal of Applied Gerontology.  733464817709532. 2017
2017 The effect of unilateral subthalamic nucleus deep brain stimulation on depression in Parkinson's diseaseBrain Stimulation.  10:651-656. 2017
2017 High hypothetical interest in physician-assisted death in multiple sclerosisNeurology.  88:1528-1534. 2017
2017 Assessment of Caregiver Inventory for Rett SyndromeJournal of Autism and Developmental Disorders.  47:1102-1112. 2017
2017 Potentially Modifiable Factors Associated With Physical Activity in Individuals With Multiple SclerosisResearch in Nursing and Health.  40:143-152. 2017
2017 Upper limb impairment is associated with use of assistive devices and unemployment in multiple sclerosisMultiple Sclerosis and Related Disorders.  13:87-92. 2017
2017 Natalizumab-associated PML: Challenges with incidence, resulting risk, and risk stratificationNeurology.  88:1197-1205. 2017
2017 Prevalence of Sun Protection at Outdoor Recreation and Leisure Venues at Resorts in North AmericaJournal of health education / Association for the Advancement of Health Education.  48:90-99. 2017
2017 Association between early childhood caries and colonization with streptococcus mutans genotypes from mothersPediatric Dentistry.  39:130-135. 2017
2017 Effects of subthalamic nucleus deep brain stimulation on objective sleep outcomes in Parkinson's disease.Movement Disorders Clinical Practice.  4:183-190. 2017
2017 Continuous electroencephalography (cEEG) monitoring and outcomes of critically Ill patientsMedical Science Monitor.  23:649-658. 2017
2017 Is multiple sclerosis a length-dependent central axonopathy? The case for therapeutic lag and the asynchronous progressive MS hypothesesMultiple Sclerosis and Related Disorders.  12:70-78. 2017
2017 A framework of care in multiple sclerosis, part 2: Symptomatic care and beyondInternational Journal of Ms Care.  19:42-56. 2017
2017 Baseline EDSS proportions in MS clinical trials affect the overall outcome and power: A cautionary noteMultiple Sclerosis.  23:982-987. 2017
2017 Comparative utility of disability progression measures in PPMS: Analysis of the PROMiSe data setNeurology, Neuroimmunology and Neuroinflammation.  4. 2017
2017 Neurocognitive Predictors of Declining Financial Capacity in Persons with Mild Cognitive ImpairmentClinical Gerontologist.  40:14-23. 2017
2017 Trigeminal neuralgia commonly precedes the diagnosis of multiple sclerosisInternational Journal of Ms Care.  19:240-246. 2017
2016 Correction to: Prevalence odds ratio versus prevalence ratio: choice comes with consequences: Prevalence odds ratio versus prevalence ratio (Statistics in Medicine, (2016), 35, 30, (5730-5735), 10.1002/sim.7059)Statistics in Medicine.  36:3760. 2016
2016 Prevalence odds ratio versus prevalence ratio: choice comes with consequencesStatistics in Medicine.  35:5730-5735. 2016
2016 Clinical trials: To catch a crook, you might try statisticsNature Reviews Neurology.  13:9-10. 2016
2016 Randomized placebo-controlled study of lovastatin in children with neurofibromatosis type 1Neurology.  87:2575-2584. 2016
2016 International clinimetric evaluation of the MG-QOL15, resulting in slight revision and subsequent validation of the MG-QOL15rMuscle and Nerve.  54:1015-1022. 2016
2016 Sustained High Level of Healthcare Worker Adherence with Hand Hygiene Practice Recommendations Using the Patient-as-Observer Approach in the Ambulatory SettingInfection Control and Hospital Epidemiology.  37:1496-1498. 2016
2016 The authors replyNew England Journal of Medicine.  375:2006-2007. 2016
2016 Examining the joint effect of disability, health behaviors, and comorbidity on mortality in MSNeurology: Clinical Practice.  6:397-408. 2016
2016 Long-term evolution of multiple sclerosis disability in the treatment eraAnnals of Neurology.  80:499-510. 2016
2016 Adjunctive azithromycin prophylaxis for cesarean deliveryNew England Journal of Medicine.  375:1231-1241. 2016
2016 Laquinimod efficacy in relapsing-remitting multiple sclerosis: How to understand why and if studies disagreeBMC Neurology.  16. 2016
2016 T cell cytokine signatures: Biomarkers in pediatric multiple sclerosisJournal of Neuroimmunology.  297:1-8. 2016
2016 Randomized trial of thymectomy in myasthenia gravisNew England Journal of Medicine.  375:511-522. 2016
2016 Health insurance affects the use of disease-modifying therapy in multiple sclerosisNeurology.  87:365-374. 2016
2016 Declines in the diagnosis of primary progressive MS: A critical change in phenotype or critical measurement error?Multiple Sclerosis.  22:983-985. 2016
2016 Impact of a switch to fingolimod on depressive symptoms in patients with relapsing multiple sclerosis: An analysis from the EPOC (Evaluate Patient OutComes) trialJournal of the Neurological Sciences.  365:190-198. 2016
2016 Placebo-controlled study in neuromyelitis optica - Ethical and design considerationsMultiple Sclerosis.  22:862-872. 2016
2016 Rigorous control conditions diminish treatment effects in weight loss-randomized controlled trialsInternational Journal of Obesity.  40:895-898. 2016
2016 Analysis of diagnoses associated with multiple sclerosis-related in-hospital mortality using the premier hospital databaseInternational Journal of Ms Care.  18:154-161. 2016
2016 Relapse May Serve as a Mediator Variable in Longitudinal Outcomes in Multiple SclerosisJournal of Neuroimaging.  26:296-302. 2016
2016 Long-term registriesNeurology: Clinical Practice.  6:97-99. 2016
2016 Relationship between symptom change, relapse activity and disability progression in multiple sclerosisJournal of the Neurological Sciences.  362:121-126. 2016
2016 Relapses in multiple sclerosis: Relationship to disabilityMultiple Sclerosis and Related Disorders.  6:10-20. 2016
2016 Post Hoc Analyses of ApoE Genotype-Defined Subgroups in Clinical TrialsJournal of Alzheimer's Disease.  50:1205-1215. 2016
2016 Extended interval dosing of natalizumab in multiple sclerosisJournal of Neurology, Neurosurgery and Psychiatry.  87:885-889. 2016
2016 A framework of care in multiple sclerosis, part 1: Updated disease classification and disease-modifying therapy use in specific circumstancesInternational Journal of Ms Care.  18:314-323. 2016
2016 Clinical Electroencephalographic Biomarker for Impending Epilepsy in Asymptomatic Tuberous Sclerosis Complex InfantsPediatric Neurology.  54:29-34. 2016
2016 Evaluation of baseline corrected QT interval and azithromycin prescriptions in an academic medical centerJournal of Hospital Medicine.  11:15-20. 2016
2016 Pooling Morphometric Estimates: A Statistical Equivalence ApproachJournal of Neuroimaging.  26:109-115. 2016
2016 Randomized trial of thymectomy in myasthenia gravisJournal of thoracic disease.  8:E1782-E1783. 2016
2016 Rationale, design, samples, and baseline sun protection in a randomized trial on a skin cancer prevention intervention in resort environmentsControlled Clinical Trials.  46:67-76. 2016
2016 Statistical Considerations for an Adaptive Design for a Serious Rare DiseaseTherapeutic Innovation & Regulatory Science.  50:375-384. 2016
2015 Sustained use of an occupational sun safety program in a recreation industry: follow-up to a randomized trial on dissemination strategiesTranslational Behavioral Medicine.  5:361-371. 2015
2015 Capacity of patients with brain metastases to make treatment decisionsPSYCHO-ONCOLOGY.  24:1448-1455. 2015
2015 Comparative Effectiveness Using A Matching-Adjusted Indirect Comparison Between Delayed-Release Dimethyl Fumarate and Fingolimod for The Treatment of Relapsing-Remitting Multiple Sclerosis.Value in Health.  18:A750. 2015
2015 Two-group time-to-event continual reassessment method using likelihood estimationControlled Clinical Trials.  45:340-345. 2015
2015 Effect of sample size re-estimation in adaptive clinical trials for Alzheimer's disease and mild cognitive impairmentAlzheimer's and Dementia: Translational Research and Clinical Interventions.  1:63-71. 2015
2015 Using baseline cognitive severity for enriching Alzheimer's disease clinical trials: How does Mini-Mental State Examination predict rate of change?Alzheimer's and Dementia: Translational Research and Clinical Interventions.  1:46-52. 2015
2015 Effect of in-painting on cortical thickness measurements in multiple sclerosis: A large cohort studyHuman Brain Mapping.  36:3749-3760. 2015
2015 Factors associated with early childhood caries incidence among high caries-risk childrenCommunity Dentistry and Oral Epidemiology.  43:366-374. 2015
2015 Factors associated with early childhood caries incidence among high caries-risk childrenCommunity Dentistry and Oral Epidemiology.  43:366-374. 2015
2015 The promise of futility trials in neurological diseasesNature Reviews Neurology.  11:300-305. 2015
2015 Differences in Alzheimer disease clinical trial outcomes based on age of the participantsNeurology.  84:1121-1127. 2015
2015 Effect of switching from intramuscular interferon β-1a to oral fingolimod on time to relapse in patients with relapsing-remitting multiple sclerosis enrolled in a 1-year extension of TRANSFORMSControlled Clinical Trials.  41:69-74. 2015
2015 A systematic review of the incidence and prevalence of autoimmune disease in multiple sclerosisMultiple Sclerosis.  21:282-293. 2015
2015 A systematic review of the incidence and prevalence of cancer in multiple sclerosisMultiple Sclerosis.  21:294-304. 2015
2015 A systematic review of the incidence and prevalence of cardiac, cerebrovascular, and peripheral vascular disease in multiple sclerosisMultiple Sclerosis.  21:318-331. 2015
2015 A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: OverviewMultiple Sclerosis.  21:263-281. 2015
2015 A systematic review of the incidence and prevalence of sleep disorders and seizure disorders in multiple sclerosisMultiple Sclerosis.  21:342-349. 2015
2015 Care partners and multiple sclerosis: Differential effect on men and womenInternational Journal of Ms Care.  17:253-260. 2015
2015 Causes of death among persons with multiple sclerosisMultiple Sclerosis and Related Disorders.  4:484-490. 2015
2015 Defining reliable disability outcomes in multiple sclerosisBrain.  138:3287-3298. 2015
2015 Impact of multiple sclerosis relapse: The NARCOMS participant perspectiveMultiple Sclerosis and Related Disorders.  4:234-240. 2015
2015 Mortality and comorbidities in patients with multiple sclerosis compared with a population without multiple sclerosis: An observational study using the US Department of Defense administrative claims databaseMultiple Sclerosis and Related Disorders.  4:546-554. 2015
2015 Multiple sclerosis drugs: How much bang for the buck?Lancet Neurology.  14:460-461. 2015
2015 Prevalence and characteristics of tremor in the NARCOMS multiple sclerosis registry: A cross-sectional surveyBMJ Open.  5. 2015
2015 Prevalence and incidence of early childhood caries among African-American children in AlabamaJournal of Public Health Dentistry.  75:42-48. 2015
2015 Prevalence of multiple sclerosis symptoms across lifespan: data from the NARCOMS RegistryNeurodegenerative Disease Management.  5:3-10. 2015
2015 Regional gray matter atrophy in relapsing remitting multiple sclerosis: Baseline analysis of multi-center dataMultiple Sclerosis and Related Disorders.  4:124-136. 2015
2015 Risk tolerance to MS therapies: Survey results from the NARCOMS registryMultiple Sclerosis and Related Disorders.  4:241-249. 2015
2015 Systematic review of interventional sickle cell trials registered in ClinicalTrials.govClinical Trials.  12:575-583. 2015
2015 The incidence and prevalence of comorbid gastrointestinal, musculoskeletal, ocular, pulmonary, and renal disorders in multiple sclerosis: A systematic reviewMultiple Sclerosis.  21:332-341. 2015
2015 The incidence and prevalence of psychiatric disorders in multiple sclerosis: A systematic reviewMultiple Sclerosis.  21:305-317. 2015
2015 The sustainability of an occupational skin cancer prevention programJournal of Occupational and Environmental Medicine.  57:1207-1213. 2015
2015 To treat or not to treat, that really is not the questionNeurology: Clinical Practice.  5:253-258. 2015
2015 Translation of a Ski School Sun Safety Program to North American Ski and Snowboard SchoolsHealth Promotion Practice.  16:560-570. 2015
2015 VHA Multiple Sclerosis Surveillance Registry and its similarities to other contemporary multiple sclerosis cohortsJournal of Rehabilitation Research and Development.  52:263-272. 2015
2014 Item response theory-based measure of global disability in multiple sclerosis derived from the Performance Scales and related itemsBMC Neurology.  14. 2014
2014 Cognition in patients with newly diagnosed brain metastasis: Profiles and implicationsJournal of Neuro-Oncology.  120:179-185. 2014
2014 Does risk stratification decrease the risk of natalizumab-associated PML? Where is the evidence?Multiple Sclerosis.  20:1304-1305. 2014
2014 Causes of death among commercially insured multiple sclerosis patients in the United StatesPLoS ONE.  9. 2014
2014 Defining the clinical course of multiple sclerosis: The 2013 revisionsNeurology.  83:278-286. 2014
2014 Patient perspectives on switching disease-modifying therapies in the NARCOMS registryPatient Preference and Adherence.  8:971-979. 2014
2014 Bifactor structure of clinical disability in relapsing multiple sclerosisMultiple Sclerosis and Related Disorders.  3:176-185. 2014
2014 Effect of nicotine replacement therapy on quitting by young adults in a trial comparing cessation servicesJournal of Public Health Management and Practice.  20. 2014
2014 Digoxin and 30-day all-cause hospital admission in older patients with chronic diastolic heart failureAmerican Journal of Medicine.  127:132-139. 2014
2014 Health literacy association with health behaviors and health care utilization in multiple sclerosis: A cross-sectional studyJournal of Medical Internet Research.  16. 2014
2014 A Full-Brain, Bootstrapped Analysis of Diffusion Tensor Imaging Robustly Differentiates Parkinson Disease from Healthy ControlsNeuroinformatics.  13:7-18. 2014
2014 Clinical trials in multiple sclerosisHandbook of Clinical Neurology.  122:445-453. 2014
2014 Composite end points to assess delay of disability progression by MS treatmentsMultiple Sclerosis.  20:1494-1501. 2014
2014 Dissemination of go sun smart in outdoor recreation: effect of program exposure on sun protection of guests at high-altitude ski areas.Journal of Health Communication.  19:999-1016. 2014
2014 Distinct populations of label-retaining cells in the adult kidney are defined temporally and exhibit divergent regional distributionsAJP - Renal Physiology.  307:F1274-F1282. 2014
2014 Does change in acetylcholine receptor antibody level correlate with clinical change in myasthenia gravis?Muscle and Nerve.  49:483-486. 2014
2014 Does natalizumab therapy benefit patients with multiple sclerosis?JAMA Neurology.  71:945-946. 2014
2014 EMA401, an orally administered highly selective angiotensin II type 2 receptor antagonist, as a novel treatment for postherpetic neuralgia: A randomised, double-blind, placebo-controlled phase 2 clinical trialLancet.  383:1637-1647. 2014
2014 Effect of APOE genotype status on targeted clinical trials outcomes and efficiency in dementia and mild cognitive impairment resulting from Alzheimer's diseaseAlzheimer's and Dementia.  10:349-359. 2014
2014 Effects of early inhaled nitric oxide therapy and vitamin A supplementation on the risk for bronchopulmonary dysplasia in premature newborns with respiratory failureJournal of Pediatrics.  164:744-748. 2014
2014 Improvement of multiple sclerosis-associated tremor as a treatment effect of natalizumabMultiple Sclerosis and Related Disorders.  3:505-512. 2014
2014 Intensive care unit readmission during childhood after preterm birth with respiratory failureJournal of Pediatrics.  164. 2014
2014 Low invasiveness of pneumococcal serotype 11A is linked to ficolin-2 recognition of O-acetylated capsule epitopes and lectin complement pathway activationJournal of Infectious Diseases.  210:1155-1165. 2014
2014 Mutans streptococci enumeration and genotype selection using different bacitracin-containing mediaJournal of Microbiological Methods.  103:53-57. 2014
2014 Natalizumab reduces relapse clinical severity and improves relapse recovery in MSMultiple Sclerosis and Related Disorders.  3:705-711. 2014
2014 No Evidence of Disease Activity: Indirect Comparisons of Oral Therapies for the Treatment of Relapsing–Remitting Multiple SclerosisAdvances in Therapy.  31:1134-1154. 2014
2014 Noninvasive inhaled nitric oxide does not prevent bronchopulmonary dysplasia in premature newbornsJournal of Pediatrics.  165:1104-1108.e1. 2014
2014 Pubertal development in rett syndrome deviates from typical femalesPediatric Neurology.  51:769-775. 2014
2014 Recruitment of participants to a multiple sclerosis trial: The CombiRx experienceClinical Trials.  11:159-166. 2014
2014 Seabed classification using surface backscattering strength versus acoustic frequency and incidence angle measured with vertical, split-beam echosoundersICES Journal of Marine Science.  71:882-894. 2014
2014 Survival in commercially insured multiple sclerosis patients and comparator subjects in the U.S.Multiple Sclerosis and Related Disorders.  3:364-371. 2014
2013 Natural history of multiple sclerosis symptomsInternational Journal of Ms Care.  15:146-158. 2013
2013 Sampling selectivity in acoustic-trawl surveys of Pacific sardine (Sardinops sagax) biomass and length distributionICES Journal of Marine Science.  70:1369-1377. 2013
2013 Cost-effectiveness analyses Beauty and the beast?Neurology: Clinical Practice.  3:436-439. 2013
2013 Epidemiological features of amyotrophic lateral sclerosis in a large clinic-based African American populationAmyotrophic Lateral Sclerosis && Frontotemporal Degeneration.  14:334-337. 2013
2013 Treatment trials in progressive MS - Current challenges and future directionsNature Reviews Neurology.  9:496-503. 2013
2013 Mortality in patients with multiple sclerosisNeurology.  81:184-192. 2013
2013 A randomized, double-blind, placebo-controlled phase II study of eculizumab in patients with refractory generalized myasthenia gravisMuscle and Nerve.  48:76-84. 2013
2013 MRI lesions: A surrogate for relapses in multiple sclerosis?Lancet Neurology.  12:628-630. 2013
2013 Characteristics of Streptococcus mutans genotypes and dental caries in childrenEuropean Journal of Oral Sciences.  121:148-155. 2013
2013 Genomic Copy Number Variants: Evidence for Association with Antibody Response to Anthrax Vaccine AdsorbedPLoS ONE.  8. 2013
2013 Cause of death in MS: Longterm follow-up of a randomised cohort, 21 years after the start of the pivotal IFNβ-1b study (BMJ Open (2012) 2 (e001972))BMJ Open.  3. 2013
2013 Constraint-induced movement therapy for the lower extremities in multiple sclerosis: Case series with 4-year follow-upArchives of Physical Medicine and Rehabilitation.  94:753-760. 2013
2013 Preferred sources of health information in persons with multiple sclerosis: Degree of trust and information soughtJournal of Medical Internet Research.  15. 2013
2013 Disability in multiple sclerosis: A reference for patients and cliniciansNeurology.  80:1018-1024. 2013
2013 Randomized study combining interferon and glatiramer acetate in multiple sclerosisAnnals of Neurology.  73:327-340. 2013
2013 Regional cortical thickness in relapsing remitting multiple sclerosis: A multi-center studyNeuroImage: Clinical.  2:120-131. 2013
2013 "Seeing" in NARCOMS: A look at vision-related quality of life in the NARCOMS registryMultiple Sclerosis.  19:953-960. 2013
2013 A genetic variant of the anti-apoptotic protein Akt predicts natalizumab-induced lymphocytosis and post-natalizumab multiple sclerosis reactivationMultiple Sclerosis.  19:59-68. 2013
2013 A retrospective review of lithium usage in veterans with multiple sclerosisMultiple Sclerosis and Related Disorders.  2:327-333. 2013
2013 EDSS variability before randomization may limit treatment discovery in primary progressive MSMultiple Sclerosis.  19:775-781. 2013
2013 Effect of glatiramer acetate on disease reactivation in MS patients discontinuing natalizumabEuropean Journal of Neurology.  20:87-94. 2013
2013 Effect of physical comorbidities on risk of depression in Multiple SclerosisInternational Journal of Ms Care.  15:34-43. 2013
2013 National variation of technical factors in computed tomography of the headJournal of Computer Assisted Tomography.  37:486-492. 2013
2013 ReplyMuscle and Nerve.  47:145-146. 2013
2013 Substantial burden of dizziness in multiple sclerosisMultiple Sclerosis and Related Disorders.  2:21-28. 2013
2013 The Multiple Sclerosis Intimacy and Sexuality Questionnaire - Re-validation and development of a 15-item version with a large US sampleMultiple Sclerosis.  19:1197-1203. 2013
2013 The magnetic resonance imaging 'rule of five': Predicting the occurrence of relapseMultiple Sclerosis.  19:1760-1764. 2013
2012 Biomarker positive and negative subjects in the ADNI cohort: Clinical characterizationCurrent Alzheimer Research.  9:1135-1141. 2012
2012 Cause of death in MS: Long-term follow-up of a randomised cohort, 21 years after the start of the pivotal IFNβ-1b studyBMJ Open.  2. 2012
2012 Inflammation, Apoptosis, and Necrosis Induced by Neoadjuvant Fas Ligand Gene Therapy Improves Survival of Dogs With Spontaneous Bone Cancer.Molecular Therapy.  20:2234-2243. 2012
2012 Personalized medicine: The return of the house call?Neurology: Clinical Practice.  2:343-351. 2012
2012 Improving the efficiency and effectiveness of pragmatic clinical trials in older adults in the United StatesControlled Clinical Trials.  33:1211-1216. 2012
2012 No association between conventional brain MR imaging and chronic cerebrospinal venous insufficiency in multiple sclerosisAmerican Journal of Neuroradiology.  33:1913-1917. 2012
2012 Treatment with interferon beta for multiple sclerosisJournal of the American Medical Association.  308:1627. 2012
2012 Short latency activation of cortex by clinically effective thalamic brain stimulation for tremorMovement Disorders.  27:1404-1412. 2012
2012 Long-Term Cost-Effectiveness Model of Interferon Beta-1b in the Early Treatment of Multiple Sclerosis in the United StatesClinical Therapeutics.  34:1966-1976. 2012
2012 Sustainability of the Dissemination of an Occupational Sun Protection Program in a Randomized TrialHealth Education and Behavior.  39:498-502. 2012
2012 Increasing age at disability milestones among MS patients in the MSBase RegistryJournal of the Neurological Sciences.  318:94-99. 2012
2012 Enhancing industry-based dissemination of an occupational sun protection program with theory-based strategies employing personal contactAmerican Journal of Health Promotion.  26:356-365. 2012
2012 Evolution of MS lesions to black holes under DNA vaccine treatmentJournal of Neurology.  259:1375-1382. 2012
2012 Adopting an evidence-based lifestyle physical activity program: Dissemination study design and methodsTranslational Behavioral Medicine.  2:199-208. 2012
2012 Psychometric evaluation of the myasthenia gravis composite using rasch analysisMuscle and Nerve.  45:820-825. 2012
2012 Recommendations for myasthenia gravis clinical trialsMuscle and Nerve.  45:909-917. 2012
2012 Short latency activation of cortex during clinically effective subthalamic deep brain stimulation for Parkinson's diseaseMovement Disorders.  27:864-873. 2012
2012 Survival in MS A randomized cohort study 21 years after the start of the pivotal IFNβ-1b trialNeurology.  78:1315-1322. 2012
2012 The CombiRx trial of combined therapy with interferon and glatiramer acetate in relapsing remitting MS: Design and baseline characteristicsMultiple Sclerosis and Related Disorders.  1:81-86. 2012
2012 The CombiRx trial of combined therapy with interferon and glatiramer cetate in relapsing remitting MS: Design and baseline characteristics.Multiple Sclerosis and Related Disorders.  1:81-86. 2012
2012 Cumulative impact of comorbidity on quality of life in MSActa Neurologica Scandinavica.  125:180-186. 2012
2012 Expanding occupational sun safety to an outdoor recreation industry: A translational study of the Go Sun Smart programTranslational Behavioral Medicine.  2:10-18. 2012
2012 Implementing clinical trials on an international platform: Challenges and perspectivesJournal of the Neurological Sciences.  313:1-6. 2012
2012 Response to the Letter 'Efficiency loss due to varying cluster sizes in cluster randomized trials and how to compensate for it: Comment on You et al. (2011)' by van Breukelen and CandelClinical Trials.  9:126-127. 2012
2012 Biomarker development for myasthenia gravisAnnals of the New York Academy of Sciences.  1275:101-106. 2012
2012 Compliance with sunscreen advice in a survey of adults engaged in outdoor winter recreation at high-elevation ski areasJournal of The American Academy of Dermatology.  66:63-70. 2012
2012 Inflammation, apoptosis, and necrosis induced by neoadjuvant fas ligand gene therapy improves survival of dogs with spontaneous bone cancerMolecular Therapy.  20:2234-2243. 2012
2012 Statistical cures and other fallaciesMultiple Sclerosis.  18:387-390. 2012
2012 Unilateral subthalamic nucleus deep brain stimulation improves sleep quality in Parkinson's diseaseParkinsonism and Related Disorders.  18:63-68. 2012
2011 Evaluation of safety monitoring guidelines based on MRI lesion activity in multiple sclerosisNeurology.  77:2089-2096. 2011
2011 Re: Practice parameters in myasthenia gravisMuscle and Nerve.  44:1001. 2011
2011 Real-time quantitative polymerase chain reaction for enumeration of Streptococcus mutans from oral samplesEuropean Journal of Oral Sciences.  119:447-454. 2011
2011 Reply from the authorsNeurology.  77. 2011
2011 To the editorNeurology.  77. 2011
2011 Inhaled nitric oxide in preterm infants: An individual-patient data meta-analysis of randomized trialsPediatrics.  128:729-739. 2011
2011 Comparison of weight changes following unilateral and staged bilateral STN DBS for advanced PDBrain and Behavior.  1:12-18. 2011
2011 Erratum: Estimating power with effect size versus slope differences: Both means and variance matter (Alzheimer's and Dementia (2011) 7 (247-249))Alzheimer's and Dementia.  7:556. 2011
2011 Molecular subtypes of osteosarcoma identified by reducing tumor heterogeneity through an interspecies comparative approachBONE.  49:356-367. 2011
2011 Motivating public school districts to adopt sun protection policies: A randomized controlled trialAmerican Journal of Preventive Medicine.  41:309-316. 2011
2011 Association between comorbidity and clinical characteristics of MSActa Neurologica Scandinavica.  124:135-141. 2011
2011 Prevalence, sensitivity, and specificity of chronic cerebrospinal venous insufficiency in MSNeurology.  77:138-144. 2011
2011 A tumor-related lymphoid progenitor population supports hierarchical tumor organization in canine B-cell lymphomaJournal of Veterinary Internal Medicine.  25:890-896. 2011
2011 Got milk?Annals of Neurology.  70:3-4. 2011
2011 A research model for investigating the effects of artificial food colorings on children with ADHDPediatrics.  127. 2011
2011 Physical activity and self-reported cardiovascular comorbidities in persons with multiple sclerosis: Evidence from a cross-sectional analysisNeuroepidemiology.  36:183-191. 2011
2011 Bayesian sample size determination under hypothesis testsControlled Clinical Trials.  32:393-398. 2011
2011 Practice parameters and focusing research: Plasma exchange for myasthenia gravisMuscle and Nerve.  43:625-626. 2011
2011 Interferon β-1b and glatiramer acetate effects on permanent black hole evolutionNeurology.  76:1222-1228. 2011
2011 Smokers with multiple sclerosis are more likely to report comorbid autoimmune diseasesNeuroepidemiology.  36:85-90. 2011
2011 Continued benefits of a technical assistance web site to local tobacco control coalitions during a state budget shortfallJournal of Public Health Management and Practice.  17. 2011
2011 Estimating power with effect size versus slop differences: Both means and variance matterAlzheimer's and Dementia.  7:247-249. 2011
2011 Estimating the density of Antarctic krill (Euphausia superba) from multi-beam echo-sounder observations using distance sampling methodsJournal of the Royal Statistical Society: Series C.  60:301-316. 2011
2011 Genetic diversity of plaque mutans streptococci with rep-PCRJournal of Dental Research.  90:331-335. 2011
2011 Chronic cerebrospinal vascular insufficiency is not associated with HLA DRB1*1501 status in multiple sclerosis patientsPLoS ONE.  6. 2011
2011 Relative efficiency and sample size for cluster randomized trials with variable cluster sizesClinical Trials.  8:27-36. 2011
2011 Risk of serious injury for young baseball pitchers: A 10-year prospective studyAmerican Journal of Sports Medicine.  39:253-257. 2011
2011 Acute kidney injury and renal replacement therapy independently predict mortality in neonatal and pediatric noncardiac patients on extracorporeal membrane oxygenationPediatric Critical Care Medicine.  12. 2011
2011 Intracortical lesions by 3T magnetic resonance imaging and correlation with cognitive impairment in multiple sclerosisMultiple Sclerosis.  17:1122-1129. 2011
2011 Substantial adverse association of visual and vascular comorbidities on visual disability in multiple sclerosisMultiple Sclerosis.  17:1464-1471. 2011
2011 Supporting tobacco control: stimulating local newspaper coverage with a technical assistance website for local coalitions.Health Promotion Practice.  12. 2011
2011 Trend for decreasing Multiple Sclerosis Severity Scores (MSSS) with increasing calendar year of enrollment into the New York State Multiple Sclerosis ConsortiumMultiple Sclerosis.  17:725-733. 2011
2010 Assessing changes in relapse rates in multiple sclerosisMultiple Sclerosis.  16:1414-1421. 2010
2010 Comparative analysis of therapeutic options used for myasthenia gravisAnnals of Neurology.  68:797-805. 2010
2010 Gene expression profiling identifies inflammation and angiogenesis as distinguishing features of canine hemangiosarcomaBMC Cancer.  10. 2010
2010 Disability progression in a clinical trial of relapsing-remitting multiple sclerosis eight-year follow-upArchives of Neurology -Chigago-.  67:1329-1335. 2010
2010 Environmental cues to UV radiation and personal sun protection in outdoor winter recreationArchives of Dermatology -Chicago-.  146:1241-1247. 2010
2010 Composite MRI scores improve correlation with EDSS in multiple sclerosisMultiple Sclerosis.  16:1117-1125. 2010
2010 Requiring an amyloid-β1-42 biomarker for prodromal Alzheimer's disease or mild cognitive impairment does not lead to more efficient clinical trialsAlzheimer's and Dementia.  6:367-377. 2010
2010 Modeling lesion counts in multiple sclerosis when patients have been selected for baseline activityMultiple Sclerosis.  16:926-934. 2010
2010 Temporal characteristics of cold pain perceptionNeuroscience Letters.  480:12-15. 2010
2010 Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosisAnnals of Neurology.  67:749-760. 2010
2010 Reply from the authorsNeurology.  74:1554-1555. 2010
2010 Variability of two plaque sampling methods in quantitation of streptococcus mutansCaries Research.  44:160-164. 2010
2010 Decreased accuracy in interpretation of community-based screening mammography for women with multiple clinical risk factorsJournal of Clinical Epidemiology.  63:441-451. 2010
2010 Inhaled Nitric Oxide in preterm infants: A systematic review and individual patient data meta-analysisBMC Pediatrics.  10. 2010
2010 Impact of loss of mobility on instrumental activities of daily living and socioeconomic status in patients with MSCurrent Medical Research and Opinion.  26:493-500. 2010
2010 A randomized, blinded, parallel-group, pilot trial of mycophenolate mofetil (CellCept) compared with interferon beta-1a (Avonex) in patients with relapsing-remitting multiple sclerosisTherapeutic Advances in Neurological Disorders.  3:15-28. 2010
2010 Considerations on discontinuing natalizumab for the treatment of multiple sclerosisAnnals of Neurology.  68:409-411. 2010
2010 Optimal design and analysis of phase I/II clinical trials in multiple sclerosis with gadolinium-enhanced lesions as the endpointMultiple Sclerosis.  16:840-847. 2010
2010 Reproducibility of high-resolution optical coherence tomography in multiple sclerosisMultiple Sclerosis.  16:829-839. 2010
2010 Sample size in obesity trials: Patient perspective versus current practiceMedical Decision Making.  30:68-75. 2010
2010 Vascular comorbidity is associated with more rapid disability progression in multiple sclerosisNeurology.  74:1041-1047. 2010
2009 Erratum to "The MGTX experience: Challenges in planning and executing an international, multicenter clinical trial" [J. Neuroimmunol. 201-202(2008)80-84] (DOI:10.1016/j.jneuroim.2008.05.031)Journal of Neuroimmunology.  217:103. 2009
2009 Evidence of treatment benefit: Is seeing believing or obfuscation by statistics?Multiple Sclerosis.  15:1251-1252. 2009
2009 Weight changes associated with unilateral STN DBS and advanced PDParkinsonism and Related Disorders.  15:709-711. 2009
2009 Clinical and economic effects of iNO in premature newborns with respiratory failure at 1 yearPediatrics.  124:1333-1343. 2009
2009 Macular volume determined by optical coherence tomography as a measure of neuronal loss in multiple sclerosisArchives of Neurology -Chigago-.  66:1366-1372. 2009
2009 A bayesian method of estimating kappa coefficient with application to a rheumatoid arthritis studyCommunications in Statistics - Theory and Methods.  38:3432-3444. 2009
2009 Vision related quality of life in multiple sclerosis: Correlation with new measures of low and high contrast letter acuityJournal of Neurology, Neurosurgery and Psychiatry.  80:767-772. 2009
2009 Testing a theory-based health communication program: A replication of go sun smart in outdoor winter recreationJournal of Health Communication.  14:346-365. 2009
2009 Variability of interpretive accuracy among diagnostic mammography facilitiesJNCI: Journal of the National Cancer Institute.  101:814-827. 2009
2009 Measuring up rates for adverse health behaviors in multiple sclerosis: The need for actionMultiple Sclerosis.  15:648. 2009
2009 Proof of concept studies for tissue-protective agents in multiple sclerosisMultiple Sclerosis.  15:542-546. 2009
2009 Multibeam echosounder observations reveal interactions between Antarctic krill and air-breathing predatorsMarine Ecology Progress Series.  378:199-209. 2009
2009 Retinal architecture predicts pupillary reflex metrics in MSMultiple Sclerosis.  15:479-486. 2009
2009 Factors that influence adherence with disease-modifying therapy in MSJournal of Neurology.  256:568-576. 2009
2009 Influence of genetic background on tumor karyotypes: Evidence for breed-associated cytogenetic aberrations in canine appendicular osteosarcomaChromosome Research.  17:365-377. 2009
2009 Polymorphisms in the NQO1, GSTT and GSTM genes are associated with coronary heart disease and biomarkers of oxidative stressMutation Research - Genetic Toxicology and Environmental Mutagenesis.  674:93-100. 2009
2009 The burden of mental comorbidity in multiple sclerosis: Frequent, underdiagnosed, and undertreatedMultiple Sclerosis.  15:385-392. 2009
2009 Magnetic resonance imaging as a potential surrogate for relapses in multiple sclerosis: A meta-analytic approachAnnals of Neurology.  65:268-275. 2009
2009 MHC-dependent desensitization of intrinsic anti-self reactivityCancer Immunology, Immunotherapy.  58:171-185. 2009
2009 Predictors of radiologists' perceived risk of malpractice lawsuits in breast imagingAmerican Journal of Roentgenology.  192:327-333. 2009
2009 Inferences and power analysis concerning two negative binomial distributions with an application to MRI lesion counts dataComputational Statistics and Data Analysis.  53:820-833. 2009
2009 Comorbidity delays diagnosis and increases disability at diagnosis in MSNeurology.  72:117-124. 2009
2009 High frequency of adverse health behaviors in multiple sclerosisMultiple Sclerosis.  15:105-113. 2009
2009 A cross-sectional study of bone health in multiple sclerosisNeurology.  73:1394-1398. 2009
2009 Editorial: Relapses in multiple sclerosis: Important or not?Neurology.  73:1612-1613. 2009
2008 Optical coherence tomography: A window into the mechanisms of multiple sclerosisNature Clinical Practice Neurology.  4:664-675. 2008
2008 Comorbidity, socioeconomic status and multiple sclerosisMultiple Sclerosis.  14:1091-1098. 2008
2008 Construction of an efficient evaluative instrument for myasthenia gravis: The MG compositeMuscle and Nerve.  38:1553-1562. 2008
2008 Smoking status over two years in patients with multiple sclerosisNeuroepidemiology.  32:72-79. 2008
2008 Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis: ReplyNeurology.  71:1747-1748. 2008
2008 Constraint-Induced Movement therapy can improve hemiparetic progressive multiple sclerosis. Preliminary findingsMultiple Sclerosis.  14:992-994. 2008
2008 Effects of program exposure and engagement with tailored prevention communication on sun protection by young adolescentsJournal of Health Communication.  13:619-636. 2008
2008 Go Sun SmartCommunication Education.  57:423-433. 2008
2008 Testing the long-term effects of the Go Sun Smart worksite health communication campaign: A group-randomized experimental studyJournal of Communication.  58:447-471. 2008
2008 The MGTX experience: Challenges in planning and executing an international, multicenter clinical trialJournal of Neuroimmunology.  201-202:80-84. 2008
2008 Bayesian interim analysis in clinical trialsControlled Clinical Trials.  29:751-755. 2008
2008 Novel design for clinical trials in multiple sclerosis: Another excursion to Sirenum scopuli?Therapy.  5:613-622. 2008
2008 Reproducibility of optical coherence tomography in multiple sclerosisArchives of Neurology -Chigago-.  65:1218-1222. 2008
2008 Less is more, or almost as much: A 15-item quality-of-life instrument for myasthenia gravisMuscle and Nerve.  38:957-963. 2008
2008 Magnetic resonance imaging as a surrogate outcome for multiple sclerosis relapsesMultiple Sclerosis.  14:770-778. 2008
2008 Retinal imaging by laser polarimetry and optical coherence tomography evidence of axonal degeneration in multiple sclerosisArchives of Neurology -Chigago-.  65:924-928. 2008
2008 Increasing Sun Protection in Winter Outdoor Recreation. A Theory-Based Health Communication ProgramAmerican Journal of Preventive Medicine.  34:502-509. 2008
2008 Mammography facility characteristics associated with interpretive accuracy of screening mammographyJNCI: Journal of the National Cancer Institute.  100:876-887. 2008
2008 Hyperglycemia and adverse pregnancy outcomesNew England Journal of Medicine.  358:1991-2002. 2008
2008 Randomized trial evaluating computer-based sun safety education for children in elementary schoolJournal of Cancer Education.  23:74-79. 2008
2008 Randomized trial on the 5 a day, the Rio Grande way website, a web-based program to improve fruit and vegetable consumption in rural communitiesJournal of Health Communication.  13:230-249. 2008
2008 Randomized trials on consider this, a tailored, internet-delivered smoking prevention program for adolescentsHealth Education and Behavior.  35:260-281. 2008
2008 Corticospinal tract abnormalities are associated with weakness in multiple sclerosisAmerican Journal of Neuroradiology.  29:333-339. 2008
2008 Ethics of placebo-controlled clinical trials in multiple sclerosis: A reassessmentNeurology.  70:1134-1140. 2008
2008 Responsiveness and predictive values in PPMS: An uncertain messageNeurology.  70:1061-1062. 2008
2008 Rules of evidence for clinical trials: The science of finding the truth?Annals of the New York Academy of Sciences.  1132:233-237. 2008
2008 Status of the thymectomy trial for nonthymomatous myasthenia gravis patients receiving prednisoneAnnals of the New York Academy of Sciences.  1132:344-347. 2008
2007 Effect of emailed messages on return use of a nutrition education website and subsequent changes in dietary behaviorJournal of Medical Internet Research.  9. 2007
2007 Inactivation of the p16 cyclin-dependent kinase inhibitor in high-grade canine non-Hodgkin's T-cell lymphomaVeterinary Pathology.  44:467-478. 2007
2007 Validation of the NARCOMS registry: DiagnosisMultiple Sclerosis.  13:770-775. 2007
2007 Disparities in the management of multiple sclerosis-related bladder symptomsNeurology.  68:1971-1978. 2007
2007 Testing the risk compensation hypothesis for safety helmets in alpine skiing and snowboardingInjury Prevention.  13:173-177. 2007
2007 Randomized trial on sun safety education at ski and snowboard schools in western North AmericaPediatric Dermatology.  24:222-229. 2007
2007 Influence of computer-aided detection on performance of screening mammographyNew England Journal of Medicine.  356:1399-1409. 2007
2007 Interferon-β for multiple sclerosis: Long-term benefits?Annals of Neurology.  61:283-285. 2007
2007 Glatiramer acetate in primary progressive multiple sclerosis: Results of a multinational, multicenter, double-blind, placebo-controlled trialAnnals of Neurology.  61:14-24. 2007
2007 Optical coherence tomography and disease subtype in multiple sclerosisNeurology.  69:2085-2092. 2007
2007 Persistent pain and uncomfortable sensations in persons with multiple sclerosisPAIN.  127:35-41. 2007
2007 Predictive value of p16 or Rb inactivation in a model of naturally occurring canine non-Hodgkin's lymphoma [7]Leukemia.  21:184-187. 2007
2007 Relation of vision to global and regional brain MRI in multiple sclerosisNeurology.  69:2128-2135. 2007
2007 Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosisNeurology.  69:1603-1609. 2007
2006 Mediation of a middle school skin cancer prevention programHealth Psychology.  25:616-625. 2006
2006 Early Inhaled Nitric Oxide Therapy in Premature Newborns with Respiratory FailureNew England Journal of Medicine.  355:354-364. 2006
2006 Canine hemangiosarcoma originates from hematopoietic precursors with potential for endothelial differentiationExperimental Hematology.  34:870-878. 2006
2006 Reality check: Perceived versus actual performance of community mammographersAmerican Journal of Roentgenology.  187:42-46. 2006
2006 Naturally occurring translational models for development of cancer gene therapyGene therapy & molecular biology.  10:31-40. 2006
2006 Change in clinician-assessed measures of multiple sclerosis and subject-reported quality of life: Results from the IMPACT studyMultiple Sclerosis.  12:180-186. 2006
2006 Does multiple sclerosis-associated disability differ between races?Neurology.  66:1235-1240. 2006
2006 Most patients with multiple sclerosis or a clinically isolated demyelinating syndrome should be treated at the time of diagnosisArchives of Neurology -Chigago-.  63:614-619. 2006
2006 Futility studies: Spending a little to save a lotNeurology.  66:626-627. 2006
2006 Impact of customized videotape education on quality of life in patients with chronic obstructive pulmonary diseaseJournal of Cardiopulmonary Rehabilitation.  26:112-117. 2006
2006 Long-term results of tacrolimus in cyclosporine- and prednisone-dependent myasthenia gravis [3]Neurology.  66:954. 2006
2006 Citrus aurantium and synephrine alkaloids in the treatment of overweight and obesity: An updateObesity Reviews.  7:79-88. 2006
2006 Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosisOphthalmology: Journal of The American Academy of Ophthalmology.  113:324-332. 2006
2006 Effects of the Sunny Days, Healthy Ways curriculum on students in grades 6 to 8American Journal of Preventive Medicine.  30:13-22. 2006
2006 Infectious causes of multiple sclerosisLancet Neurology.  5:887-894. 2006
2005 Estimating long-term effects of disease-modifying drug therapy in multiple sclerosis patientsMultiple Sclerosis.  11:626-634. 2005
2005 Changes in the ascertainment of multiple sclerosisNeurology.  65:1066-1070. 2005
2005 MRI as a marker for disease heterogeneity in multiple sclerosisNeurology.  65:1071-1076. 2005
2005 Validation of the NARCOMS Registry: Fatique assessmentMultiple Sclerosis.  11:583-584. 2005
2005 Randomized trial testing a worksite sun protection program in an outdoor recreation industryHealth Education and Behavior.  32:514-535. 2005
2005 Distinct B-cell and T-cell lymphoproliferative disease prevalence among dog breeds indicates heritable riskCancer Research.  65:5654-5661. 2005
2005 Does litigation influence medical practice? The influence of community radiologists' medical malpractice perceptions and experience on screening mammographyRadiology.  236:37-46. 2005
2005 Is Bayesian analysis ready for use in phase III randomized clinical trials? Beware the sound of the sirensStroke.  36:1622-1623. 2005
2005 The Goldman Consensus statement on depression in multiple sclerosisMultiple Sclerosis.  11:328-337. 2005
2005 Validation of the NARCOMS registry: Pain assessmentMultiple Sclerosis.  11:338-342. 2005
2005 Current realities of delivering mammography services in the community: Do challenges with staffing and scheduling exist?Radiology.  235:391-395. 2005
2005 Mammographers' perception of women's breast cancer riskMedical Decision Making.  25:283-289. 2005
2005 Exactly which synephrine alkaloids does Citrus aurantium (bitter orange) contain?International Journal of Obesity.  29:443-446. 2005
2005 Low-contrast letter acuity testing captures visual dysfunction in patients with multiple sclerosisNeurology.  64:992-995. 2005
2005 Physician predictors of mammographic accuracyJNCI: Journal of the National Cancer Institute.  97:358-367. 2005
2005 Assessing accuracy of mammography in the presence of verification bias and intrareader correlationBiometrics.  61:259-268. 2005
2005 Association between mammography timing and measures of screening performance in the United StatesRadiology.  234:363-373. 2005
2005 Community-based mammography practice: Services, charges, and interpretation methodsAmerican Journal of Roentgenology.  184:433-438. 2005
2005 Randomized effectiveness trial of a computer-assisted intervention to improve diabetes careDiabetes Care.  28:33-39. 2005
2004 Accuracy of screening mammography interpretation by characteristics of radiologistsJNCI: Journal of the National Cancer Institute.  96:1840-1850. 2004
2004 A practical randomized trial to improve diabetes careJournal of General Internal Medicine.  19:1167-1174. 2004
2004 Prevalence and diffusion of helmet use at ski areas in Western North America in 2001-02Injury Prevention.  10:358-362. 2004
2004 CCR2-64I polymorphism and CCR5Δ32 deletion in patients with Alzheimer's diseaseJournal of the Neurological Sciences.  225:79-83. 2004
2004 Clinical characteristics of progressive relapsing multiple sclerosisMultiple Sclerosis.  10:451-454. 2004
2004 Effect of breast augmentation on the accuracy of mammography and cancer characteristicsWomen's Oncology Review.  4:163-164. 2004
2004 The MS Co-Operative Research (MS-CORE) group: An alternate approach to fostering multicenter studies [1]Multiple Sclerosis.  10:332-333. 2004
2004 The association between obesity and screening mammography accuracyArchives of Internal Medicine -New Series-.  164:1140-1147. 2004
2004 Radiologist uncertainty and the interpretation of screeningMedical Decision Making.  24:255-264. 2004
2004 The patient's perception of a (reliable) change in the Multiple Sclerosis Functional CompositeMultiple Sclerosis.  10:55-60. 2004
2004 Effect of Breast Augmentation on the Accuracy of Mammography and Cancer CharacteristicsJournal of the American Medical Association.  291:442-450. 2004
2003 Effect of relapses on development of residual deficit in multiple sclerosisNeurology.  61:1528-1532. 2003
2003 Prognostic characteristics of breast cancer among postmenopausal hormone users in a screened populationJournal of Clinical Oncology.  21:4314-4321. 2003
2003 Contrast letter acuity as a visual component for the Multiple Sclerosis Functional CompositeNeurology.  61:1367-1373. 2003
2003 Enhancing antimelanoma immune responses through apoptosisCancer Gene Therapy.  10:726-736. 2003
2003 Sample size estimates for determining treatment effects in high-risk patients with early relapsing-remitting multiple sclerosisMultiple Sclerosis.  9:289-292. 2003
2003 Optimization of technique factors for a silicon diode array full-field digital mammography system and comparison to screen-film mammography with matched average glandular doseMedical Physics.  30:334-340. 2003
2003 Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammographyAnnals of Internal Medicine.  138:168-175. 2003
2003 Factors that predict health-related quality of life in patients with relapsing-remitting multiple sclerosisMultiple Sclerosis.  9:1-5. 2003
2003 The prevalence and predictors of helmet use by skiers and snowboarders at ski areas in western north america in 2001Journal of Trauma.  55:939-945. 2003
2002 Eight-year follow-up study of brain atrophy in patients with MSNeurology.  59:1412-1420. 2002
2002 Detection of ductal carcinoma in situ in women undergoing screening mammographyJNCI: Journal of the National Cancer Institute.  94:1546-1554. 2002
2002 Benefit of interferon β-1a on MSFC progression in secondary progressive MSNeurology.  59:679-687. 2002
2002 Performance of diagnostic mammography for women with signs or symptoms of breast cancerJNCI: Journal of the National Cancer Institute.  94:1151-1159. 2002
2002 Clinical comparison of full-field digital mammography and screen-film mammography for detection of breast cancerAmerican Journal of Roentgenology.  179:671-677. 2002
2002 Mammography screening and differences in stage of disease by race/ethnicityAmerican Journal of Public Health.  92:1144-1150. 2002
2002 Performance comparison of full-field digital mammography to screen-film mammography in clinical practiceMedical Physics.  29:830-834. 2002
2002 The Multiple Sclerosis Functional Composite: A new clinical outcome measure for multiple sclerosis trialsMultiple Sclerosis.  8:359-365. 2002
2001 Modelling new enhancing MRI lesion counts in multiple sclerosisMultiple Sclerosis.  7:298-304. 2001
2001 Competing demands in the office visit: What influences mammography recommendations?Journal of the American Board of Family Medicine.  14:352-361. 2001
2001 Use of the multiple sclerosis functional composite to predict disability in relapsing MSNeurology.  56:1324-1330. 2001
2001 Hypothermia as a risk factor for pediatric cardiothoracic surgical site infectionPediatric Infectious Disease Journal.  20:459-462. 2001
2001 Comparison of full-field digital mammography with screen-film mammography for cancer detection: Results of 4,945 paired examinationsRadiology.  218:873-880. 2001
2001 Rates and causes of disagreement in interpretation of full-field digital mammography and film-screen mammography in a diagnostic settingAmerican Journal of Roentgenology.  176:1241-1248. 2001
2001 The effect of degree of refractive error on hydrogel contact lens-induced complications and patient self-management behaviorsOptometry and Vision Science.  78:652-656. 2001
2001 Use of the multiple sclerosis functional composite as an outcome measure in a phase 3 clinical trialArchives of Neurology -Chigago-.  58:961-967. 2001
2000 Performance of screening mammography among women with and without a first-degree relative with breast cancerAnnals of Internal Medicine.  133:855-863. 2000
2000 Clinical significance of the multiple sclerosis functional composite: Relationship to patient-reported quality of lifeArchives of Neurology -Chigago-.  57:1319-1324. 2000
2000 Intrarater and interrater reliability of the MS functional composite outcome measureNeurology.  54:802-806. 2000
2000 Validity of self-reported colorectal cancer screening behaviorCancer Epidemiology, Biomarkers and Prevention.  9:229-232. 2000
2000 New low-contrast vision charts: Reliability and test characteristics in patients with multiple sclerosisMultiple Sclerosis.  6:163-171. 2000
2000 Relationship between brain atrophy and disability: An 8-year follow-up study of multiple sclerosis patientsMultiple Sclerosis.  6:373-377. 2000
2000 Self-reported visual dysfunction in multiple sclerosis: Results from the 25-Item National Eye Institute Visual Function Questionnaire (VFQ-25)Multiple Sclerosis.  6:382-385. 2000
1999 Inhaled nitric oxide in premature neonates with severe hypoxaemic respiratory failure: A randomised controlled trialLancet.  354:1061-1065. 1999
1999 The Multiple Sclerosis Functional Composite Measure (MSFC): an integrated approach to MS clinical outcome assessment. National MS Society Clinical Outcomes Assessment Task Force.Multiple Sclerosis.  5:244-250. 1999
1999 Development of a multiple sclerosis functional composite as a clinical trial outcome measureBrain.  122:871-882. 1999
1999 A study of the relationship between family history of breast cancer and knowledge of breast cancer genetic testing prerequisitesCancer Detection and Prevention.  23:22-30. 1999
1999 Practice patterns of family physicians in practice-based research networks: a report from ASPN. Ambulatory Sentinel Pratice Network.Journal of the American Board of Family Medicine.  12:278-284. 1999
1999 Promoting cancer screening among the first-degree relatives of breast and colorectal cancer patients: The design of two randomized trialsPreventive Medicine.  28:229-242. 1999
1998 The prospective relationships between smoking and weight in a young, biracial cohort: The Coronary Artery Risk Development in Young Adults studyJournal of Consulting and Clinical Psychology.  66:987-993. 1998
1998 The pediatric costs of strategies for minimizing the risk of early- onset group B streptococcal disease [1] (multiple letters)Obstetrics and Gynecology.  91:156-157. 1998
1998 Improvement in mammography quality control: 1987-1995Radiology.  207:663-668. 1998
1998 Pathogenetic characterization of 1-methyl-1-nitrosourea-induced mammary carcinomas in the ratCarcinogenesis.  19:223-227. 1998
1998 The cancer information service research consortium: An emerging laboratory for cancer control researchPreventive Medicine.  27. 1998
1997 The pediatric costs of strategies for minimizing the risk of early- onset group B streptococcal diseaseObstetrics and Gynecology.  90:347-352. 1997
1997 Randomized, multicenter trial of inhaled nitric oxide and high-frequency oscillatory ventilation in severe, persistent pulmonary hypertension of the newborn.Journal of Pediatrics.  131:55-62. 1997
1997 Long-term survival of African Americans in the Coronary Artery Surgery Study (CASS)Journal of the American College of Cardiology.  29:358-364. 1997
1997 A classification system to evaluate weight maintainers, gainers, and losersJournal of The American Dietetic Association.  97:481-488. 1997
1997 Evaluating the value of low-vision services.Journal- American Optometric Association.  68:287-295. 1997
1997 Randomized, multicenter trial of inhaled nitric oxide and high-frequency oscillatory ventilation in severe, persistent pulmonary hypertension of the newbornJournal of Pediatrics.  131:55-62. 1997
1997 Recommendations from the national multiple sclerosis society clinical outcomes assessment task forceAnnals of Neurology.  42:379-382. 1997
1996 Clinical outcomes assessment in multiple sclerosisAnnals of Neurology.  40:469-479. 1996
1996 Clinical outcomes assessment in multiple sclerosis: Part IIMultiple Sclerosis.  2:247-248. 1996
1996 Impact of maternal group B streptococcal screening on pediatric management in full-term newbornsArchives of Pediatrics and Adolescent Medicine.  150:802-808. 1996
1996 Methodological issues in weight cyclingAnnals of Behavioral Medicine.  18:280-289. 1996
1996 The clinical presentation, prevalence, and risk factors of focal corneal infiltrates in soft contact lens wearersClao Journal.  22:30-36. 1996
1995 Strategies for the prevention of early-onset neonatal group B streptococcal sepsis: a decision analysisACOG Current Journal Review.  8:18-19. 1995
1995 The association of heparin exposure with intraventricular hemorrhage among very low birth weight infants.Journal of Perinatology.  15:185-191. 1995
1995 Psychological correlates of weight fluctuation.International Journal of Eating Disorders.  17:263-275. 1995
1995 Optometric Care and Undetected Eye Disease: A Case of Berkson's Bias?Archives of Internal Medicine -New Series-.  155:427-429. 1995
1995 Cervical examination and tocodynamometry at 28 weeks' gestation: prediction of spontaneous preterm birth.American Journal of Obstetrics and Gynecology.  172:666-671. 1995
1995 A new device for collecting cord bloodObstetrics and Gynecology.  86:850-852. 1995
1995 Cervical examination and tocodynamometry at 28 weeks' gestation: Prediction of spontaneous preterm birthAmerican Journal of Obstetrics and Gynecology.  172:666-671. 1995
1995 Clinical outcomes and documentation of partial beneficial effects of immunotherapy for multiple sclerosisAnnals of Neurology.  37:5-6. 1995
1995 Differences in the detection and enumeration of mutans streptococci due to differences in methodsArchives of Oral Biology.  40:345-351. 1995
1995 Fetal growth in women using low-dose aspirin for the prevention of preeclampsia: Effect of maternal sizeJournal of Maternal-Fetal and Neonatal Medicine.  4:218-224. 1995
1995 Impact of patient history on residents' evaluation of child sexual abuseChild Abuse and Neglect.  19:943-951. 1995
1995 Low-dose aspirin: Lack of association with an increase in abruptio placentae or perinatal mortalityObstetrics and Gynecology.  85:1055-1058. 1995
1995 Maternal serum thromboxane B2 reduction versus pregnancy outcome in a low-dose aspirin trialAmerican Journal of Obstetrics and Gynecology.  173:578-584. 1995
1995 Psychological correlates of weight fluctuationInternational Journal of Eating Disorders.  17:263-275. 1995
1995 The Effect of Cigarette Smoking on Neonatal Anthropometric MeasurementsObstetrics and Gynecology.  85:625-630. 1995
1995 The relationship between maternal and neonatal anthropometric measurements in term newbornsObstetrics and Gynecology.  85:192-196. 1995
1995 The self-management behaviors of soft contact lens wearers: The effect of lens modalityInternational Contact Lens Clinic.  22:117-123. 1995
1995 Who Are the Weight Maintainors?Obesity Research.  3:249s-259s. 1995
1994 A study of the reliability and comparative validity of the cardia dietary history.Ethnicity and Disease.  4:15-27. 1994
1994 Bed rest in pregnancyObstetrics and Gynecology.  84:131-136. 1994
1994 Characteristics of severe hypoglycemia in the patient with insulin-dependent diabetesSouthern Medical Journal.  87:616-620. 1994
1994 Data discrepancies and audit effects in the umbilical artery catheter trialDrug Information Journal.  28:891-897. 1994
1994 Diagnoses, symptoms, and attribution of symptoms among black and white inpatients admitted for coronary heart diseaseAmerican Journal of Public Health.  84:951-956. 1994
1994 Effect of a National Cancer Institute Clinical Alert on breast cancer practice patternsJournal of Clinical Oncology.  12:1783-1788. 1994
1994 Strategies for the prevention of early-onset neonatal group B streptococcal sepsis: A decision analysisObstetrics and Gynecology.  83:483-494. 1994
1993 Rose Questionnaire responses among black and white inpatients admitted for coronary heart disease: findings from the Birmingham-BHS Project.Ethnicity and Disease.  3:290-302. 1993
1993 Fetal biparietal diameter, head circumference, abdominal circumference and femur length: A comparison by race and sexJournal of Reproductive Medicine.  38:201-206. 1993
1993 Promoting physical activity in low-income African-American communities: the PARR project.Ethnicity and Disease.  3:106-118. 1993
1993 Initial Acquisition of Mutans Streptococci by Infants: Evidence for a Discrete Window of InfectivityJournal of Dental Research.  72:37-45. 1993
1993 Low-dose aspirin therapy to prevent preeclampsiaAmerican Journal of Obstetrics and Gynecology.  168:1083-1093. 1993
1993 Maternal risk factors and their influence on fetal anthropometric measurementsAmerican Journal of Obstetrics and Gynecology.  168:1197-1205. 1993
1993 Physical activity of public housing residents in Birmingham, AlabamaAmerican Journal of Public Health.  83:1016-1020. 1993
1993 Radiographic Changes Associated with Tracheal Isolation of Ureaplasma Urealyticum from NeonatesClinical Infectious Diseases.  17:S122-S130. 1993
1993 The feasibility of long-term treatment of diabetes with continuous subcutaneous insulin infusionDiabetes Nutrition and Metabolism.  6:57-60. 1993
1993 The relationship between maternal hematocrit and pregnancy outcome: black-white differences.Journal of the National Medical Association.  85:130-134. 1993
1993 Transmission of mutans streptococci to infants following short term application of an iodine‐NaF solution to mothers' dentitionCommunity Dentistry and Oral Epidemiology.  21:136-142. 1993
1992 Serum folate and fetal growth retardation: a matter of compliance?Obstetrics and Gynecology.  79:719-722. 1992
1992 Blood pressure, growth retardation, and preterm deliveryInternational Journal of Technology Assessment in Health Care.  8:82-90. 1992
1992 Distributed data analysis in a multicenter study: The CARDIA studyControlled Clinical Trials.  13:80-90. 1992
1992 Effect of conventional dental restorative treatment on bacteria in salivaCommunity Dentistry and Oral Epidemiology.  20:138-143. 1992
1992 Elevated levels of midtrimester maternal serum α-fetoprotein are associated with preterm delivery but not with fetal growth retardationAmerican Journal of Obstetrics and Gynecology.  167:596-601. 1992
1992 Factors predicting efficacy of phentolamine-papaverine intracorporeal injection for treatment of erectile dysfunction in diabetic maleUrology.  40:36-40. 1992
1992 Maternal serum folate and zinc concentrations and their relationships to pregnancy outcomeAmerican Journal of Clinical Nutrition.  56:365-370. 1992
1992 Relationship of intraventricular hemorrhage or death with the level of umbilical artery catheter placement: A multicenter randomized clinical trialPediatrics.  90:881-887. 1992
1992 Serum folate and fetal growth retardation: A matter of compliance?Obstetrics and Gynecology.  79:719-722. 1992
1992 Symptom-limited graded treadmill exercise testing in young adults in the CARDIA studyMedicine and science in sports.  24:177-183. 1992
1992 The influence of previous low birth weight on birth weight, gestational age, and anthropometric measurements in the current pregnancyObstetrics and Gynecology.  79:276-280. 1992
1992 The relationships among psychosocial profile, maternal size, and smoking in predicting fetal growth retardationObstetrics and Gynecology.  80:262-267. 1992
1992 Usefulness of various maternal skinfold measurements for predicting newborn birth weightJournal of The American Dietetic Association.  92:1393-1394. 1992
1991 Black-white differences in newborn anthropometric measurements.Obstetrics and Gynecology.  78:782-788. 1991
1991 Cardiovascular risk factors in young adults. The CARDIA baseline monograph.Controlled Clinical Trials.  12:1S-77S. 1991
1991 Black-white differences in newborn anthropometric measurementsObstetrics and Gynecology.  78:782-788. 1991
1991 Cardiovascular risk factors in young adults. The CARDIA baseline monographControlled Clinical Trials.  12:1-77. 1991
1991 Maternal serum alpha<inf>2</inf>-macroglobulin and fetal growth retardationObstetrics and Gynecology.  78:594-599. 1991
1991 Oral leukoplakia and adolescent smokeless tobacco useOral surgery, oral medicine, and oral pathology.  72:35-41. 1991
1991 Risk factors and the natural history of coronary heart disease in blacksCardiovascular clinics.  21:29-45. 1991
1991 The relationship between maternal hematocrit and pregnancy outcomeObstetrics and Gynecology.  77:190-194. 1991
1991 The relationship between maternal serum zinc levels during pregnancy and birthweightEarly Human Development.  25:75-85. 1991
1990 Estimating the Mean, Variance, and Confidence Limits from Censored (Limit of Detection), Lognormally-Distributed Exposure DataAmerican Industrial Hygiene Association Journal.  51:416-419. 1990
1990 A positive association between maternal serum zinc concentration and birth weightAmerican Journal of Clinical Nutrition.  51:678-684. 1990
1990 Alcohol intake and blood pressure in young adults: The CARDIA studyJournal of Clinical Epidemiology.  43:1-13. 1990
1990 Cigarette smoking behavior is strongly related to educational status: The cardia studyPreventive Medicine.  19:158-169. 1990
1990 Intrauterine growth retardation and preterm delivery: prenatal risk factors in an indigent populationAmerican Journal of Obstetrics and Gynecology.  162:213-218. 1990
1990 Intrauterine growth retardation is not the same as small for gestational age (I: Reply)American Journal of Obstetrics and Gynecology.  162:1643. 1990
1990 Racial differences in serum cotinine levels among smokers in the Coronary Artery Risk Development in (Young) Adults StudyAmerican Journal of Public Health.  80:1053-1056. 1990
1990 ReplyAmerican Journal of Obstetrics and Gynecology.  162:1643. 1990
1990 Smoking, maternal age, fetal growth, and gestational age at deliveryAmerican Journal of Obstetrics and Gynecology.  162:53-58. 1990
1990 The effect of thiazide therapy on glucose, insulin and cholesterol metabolism and of glucose on potassium: Results of a cross-sectional study in patients from the Hypertension Detection and Follow-up ProgramJournal of Human Hypertension.  4:491-500. 1990
1990 Warning symptoms, uterine contractions, and cervical examination findings in women at risk of preterm deliveryAmerican Journal of Obstetrics and Gynecology.  162:748-754. 1990
1989 Efficacy of a premixed semisynthetic human insulin regimenClinical Therapeutics.  11:795-801. 1989
1989 Patient preference between clear and yellow lenses for binocular indirect ophthalmoscopyClinical Eye and Vision Care.  1:163-165. 1989
1989 A Randomized, Controlled Trial of Very Early Prophylactic Ligation of the Ductus Arteriosus in Babies Who Weighed 1000 g or Less at BirthNew England Journal of Medicine.  320:1511-1516. 1989
1989 Effects of very low birth weights on fetal and neonatal mortality rates in AlabamaPublic Health Reports.  104:488-492. 1989
1989 Ethnic differences in blood pressure, pulse rate, and related characteristics in young adults. The CARDIA studyHypertension.  14:218-226. 1989
1989 Fluorescence microscopy of DES‐induced morphologic transformation in unfixed, cultured cellsJournal of Oral Pathology and Medicine.  18:451-456. 1989
1989 Intrauterine growth retardation: Standards for diagnosisAmerican Journal of Obstetrics and Gynecology.  161:271-277. 1989
1989 Portable tonometers: a clinical comparison of applanation and indentation devices.Journal- American Optometric Association.  60:105-110. 1989
1989 Preliminary Results From The Collaborative Alabama And Scandinavian Study Of Successive Small‐For‐Gestational Age Births: Report From a Symposium In Trondheim 9th June 1988Acta Obstetricia et Gynecologica Scandinavica.  68:19-25. 1989
1989 Prematurity, postdates, and growth retardation: The influence of use of ultrasonography on reported gestational ageAmerican Journal of Obstetrics and Gynecology.  160:462-470. 1989
1989 Sensitivity, specificity and predictive value of saliva thiocyanate among pregnant womenAddictive Behaviors.  14:447-452. 1989
1988 ASSOCIATION OF UREAPLASMA UREALYTICUM INFECTION OF THE LOWER RESPIRATORY TRACT WITH CHRONIC LUNG DISEASE AND DEATH IN VERY-LOW-BIRTH-WEIGHT INFANTSLancet.  332:240-245. 1988
1988 A cost-effectiveness analysis of self-help smoking cessation methods for pregnant womenPublic Health Reports.  103:83-88. 1988
1988 Cardia: study design, recruitment, and some characteristics of the examined subjectsJournal of Clinical Epidemiology.  41:1105-1116. 1988
1988 Condylomata acuminata in IDDM.Diabetes Care.  11:295-296. 1988
1988 Cost-effectiveness of prevention, intervention, and therapeutic strategies in coronary artery diseaseDrug Information Journal.  22:425-448. 1988
1988 Cost-effectiveness of prevention, intervention, and therapeutic strategies in coronary artery diseaseTherapeutic Innovation & Regulatory Science.  22:425-448. 1988
1988 Factors associated with discontinuation of continuous subcutaneous insulin infusionAmerican Journal of the Medical Sciences.  295:23-28. 1988
1988 Plasmid-containing strains of Streptococcus mutans cluster within family and racial cohorts: Implications for natural transmissionInfection and Immunity.  56:3216-3220. 1988
1988 Relationships of low density lipoprotein cholesterol with age and other factors: A cross-sectional analysis of the CARDIA studyAnnals of clinical research.  20:32-38. 1988
1987 A study of the cost of tuberculosis contact investigation related to non-tuberculous Mycobacterial isolation in Jefferson County, AlabamaPublic Health.  101:297-304. 1987
1987 Comparison of hypertension prevalence and control in 5,237 rural and urban Alabama residentsSouthern Medical Journal.  80:1220-1223. 1987
1987 Fetal deaths in Alabama, 1974-1983: A birth weight-specific analysisObstetrics and Gynecology.  70:831-835. 1987
1987 Recruitment in the Coronary Artery Disease Risk Development in Young Adults (Cardia) studyControlled Clinical Trials.  8:68-73. 1987
1986 Prediction of response to sodium intervention for blood pressure controlJournal of Hypertension.  4. 1986
1986 DDT contamination of a North Alabama aquatic ecosystemEnvironmental Toxicology and Chemistry.  5:725-736. 1986
1985 Low birth weight, intrauterine growth retardation, and preterm deliveryAmerican Journal of Obstetrics and Gynecology.  152:980-984. 1985
1985 Dietary therapy slows the return of hypertension after stopping prolonged medicationJournal of the American Medical Association.  253:657-664. 1985
1985 Neonatal mortality in infants born weighing 501 to 1000 grams. The influence of changes in birth weight distribution and birth weight-specific mortality rates on neonatal survivalAmerican Journal of Obstetrics and Gynecology.  151:608-611. 1985
1985 Dietary Therapy Slows the Return of Hypertension After Stopping Prolonged MedicationJournal of the American Medical Association.  253:657-664. 1985
1985 Late results of surgical and medical therapy for patients with coronary artery disease and depressed left ventricular functionJournal of the American College of Cardiology.  5:1036-1045. 1985
1985 The Risk of Bladder Calculi in Patients With Spinal Cord InjuriesArchives of Internal Medicine -New Series-.  145:428-430. 1985
1985 The effectiveness of smoking cessation methods for smokers in public health maternity clinics: A randomized trialAmerican Journal of Public Health.  75:1389-1392. 1985
1985 The natural history of smoking cessation among patients undergoing coronary arteriographyJournal of Cardiac Rehabilitation.  5:332-340. 1985
1984 Does effective antihypertensive therapy partially "cure" hypertension?Transactions- American Clinical and Climatological Association.  96:111-119. 1984
1984 Effect of dietary change on the return of hypertension after withdrawal of prolonged antihypertensive therapy (DISH)Journal of Hypertension.  2:179-181. 1984
1984 Effect of dietary change on the return of hypertension after withdrawal of prolonged antihypertensive therapy (DISH). Dietary Intervention Study of Hypertension.Journal of Hypertension -Supplement-.  2:S179-S181. 1984
1984 Return of hypertension after withdrawal of prolonged antihypertensive therapy, effect of weight loss, sodium reduction, and baseline factors.Transactions of the Association of American Physicians.  97:190-196. 1984
1984 Association of factor B with ischemic heart disease (IHD).Progress in clinical and biological research.  147:479-480. 1984
1984 Issues in the natural history and treatment of coronary heart disease in black populations: Surgical treatmentAmerican Heart Journal.  108:688-694. 1984
1984 The risk of renal calculi in spinal cord injury patientsJournal of Urology, The.  131:857-859. 1984
1983 Hypertension detection and follow-up program. Baseline medical history characteristics of the hypertensive participants.Hypertension.  5. 1983
1983 Hypertension detection and follow-up program. Baseline physical examination characteristics of the hypertensive participants.Hypertension.  5. 1983
1983 An assessment of the environmental protection agency's asbestos hazard evaluation algorithmAmerican Journal of Public Health.  73:1179-1181. 1983
1983 Baseline medical history characteristics of the hypertensive participantsHypertension.  5:51-91. 1983
1983 Baseline physical examination characteristics of the hypertensive participantsHypertension.  5:92-132. 1983
1983 Quasi-experimental designs for evaluating cancer control programs in rural settings.Progress in clinical and biological research.  120:55-70. 1983
1983 Training and certification of blood pressure observersHypertension.  5:610-614. 1983
1982 Epidemiologic study of candidates for coronary artery bypass surgery.Circulation.  66:III6-II15. 1982
1982 Correlates of attendance and compliance in the hypertension detection and follow-up programControlled Clinical Trials.  3:13-27. 1982
1982 Epidemiologic study of candidates for coronary artery bypass surgeryCirculation.  66. 1982
1982 Methodological issues in using time series designs and analysis: evaluating the behavioral impact of health communication programs.Progress in clinical and biological research.  83:517-535. 1982
1982 Three-year incidence of hypertension in thirteen U.S. communities. On behalf of the hypertension detection and follow-up program cooperative groupPreventive Medicine.  11:487-499. 1982
1982 Validation of a risk function to predict mortality in a VA population with coronary artery diseaseControlled Clinical Trials.  3:47-60. 1982
1981 Urinary Glycosaminoglycan Excretion as a Biochemical Marker in Patients with Bladder CarcinomaCancer Research.  41:3868-3873. 1981
1981 Increasing utilization of a rural cervical cancer detection programAmerican Journal of Public Health.  71:641-643. 1981
1980 A two-compartment regression model applied to compliance in a hypertension treatment programJournal of chronic diseases.  33:645-651. 1980
1980 Application of survival analysis techniques to evaluation of factors affecting compliance in a clinical trial of hypertension controlControlled Clinical Trials.  1:59-69. 1980
1980 Impact of hypertension information on high blood pressure control between 1973 and 1978Hypertension.  2:708-713. 1980
1980 Mortality surveillance in collaborative trialsAmerican Journal of Public Health.  70:394-400. 1980
1976 SODIUM EXCRETION AND SYMPATHETIC ACTIVITY IN RELATION TO SEVERITY OF HYPERTENSIVE DISEASELancet.  308:471. 1976
1976 Some examples for teaching regression toward the mean from a sampling viewpointAmerican Statistician.  30:194-197. 1976
1886 Injustice to Dr. barnesJournal of the American Medical Association.  VI:498. 1886

Chapter

Year Title Altmetric
2017 Women and neurological disability: End-of-life care and mortality in women with MS.  113-126. 2017
2014 Association, cause, and correlation.  345-362. 2014
2012 Multiple sclerosis.  257-272. 2012
2011 Measures of neurological impairment and disability in multiple sclerosis.  56-64. 2011
2008 Association, cause, and correlation.  279-294. 2008
2008 Defining Responders and Non-responders: Clinical and Statistical Aspects. 2008
2007 Observational Studies 2007
2001 Observational Studies 2001
2001 Therapeutic considerations: Rating scales.  465-491. 2001

Principal Investigator On

  • Discontinuation of Disease Modifying Therapies (DMTs) in Multiple Sclerosis (MS)  awarded by University of Colorado 2016 - 2021
  • Phase I Clinical Trial in Humans using Human Fetal Derived Glial Restricted Progenitor Cells ("Q Cells") In Transverse Myelitis  awarded by THE TRAVERSE MYELITIS ASSOCIATION 2019 - 2021
  • ChLorthalidone In Chronic Kidney Disease (CLICK) Study  awarded by Indiana University 2017 - 2020
  • CMSC/NARCOMS Project  awarded by CONSORTIUM OF MULTIPLE SCLEROSIS CENTERS 2008 - 2020
  • Chronic Hypertension and Pregnancy (CHAP): Data Coordinating Center  awarded by National Heart, Lung, and Blood Institute/NIH/DHHS 2014 - 2020
  • National Resource Center for High-Impact Clinical Trials in Medical Rehabilitation: Collaborative Opportunities  awarded by National Institute of Child Health and Human Development/NIH/DHHS 2015 - 2020
  • Myasthenia Gravis Patient Registry Work Order #4  awarded by Myasthenia Gravis Foundation of America, Inc. 2017 - 2019
  • Myasthenia Gravis Patient Registry Work Order #5  awarded by Myasthenia Gravis Foundation of America, Inc. 2017 - 2019
  • Myasthenia Gravis Patient Registry Work Order #6  awarded by Myasthenia Gravis Foundation of America, Inc. 2017 - 2019
  • Myasthenia Gravis Patient Registry Work Order #7  awarded by Myasthenia Gravis Foundation of America, Inc. 2017 - 2019
  • Early Biomarkers of Autism Spectrum Disorders in Infants with Tuberous Sclerosis  awarded by CHILDREN'S HOSPITAL (BOSTON) 2013 - 2019
  • The UAB STI CRC - DiSCIS Biostatistics & Bioinformatics Core  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2014 - 2019
  • UAB Center for AIDS Research - Biostats Core D  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2014 - 2019
  • Premature Infants Receiving Cord Milking Or Delayed Cord Clamping  awarded by SHARP HEALTHCARE FOUNDATION 2017 - 2019
  • Myasthenia Gravis Patient Registry Work Order #2  awarded by Myasthenia Gravis Foundation of America, Inc. 2016 - 2018
  • Myasthenia Gravis Patient Registry Work Order #1  awarded by Myasthenia Gravis Foundation of America, Inc. 2016 - 2018
  • Collaborative Assessment of Pediatric Transverse Myelitis: Understand, Reveal, Educate (CAPTURE) Study  awarded by University of Texas Southwestern Medical Center at Dallas 2013 - 2018
  • Thymectomy in Non-Thymomatous MG Patients on Prednisone  awarded by National Institute of Neurological Disorders and Stroke/NIH/DHHS 2010 - 2017
  • Extension of Combination Therapy in Multiple Sclerosis (eCombiRx)  awarded by MT. SINAI MEDICAL CENTER 2007 - 2015
  • Synthesis of Longer-Term Alzheimer Disease Studies in Order to Model and Improve Clinical Trials Methods and Outcomes: Alzheimer Disease Clinical  awarded by University of Southern California 2011 - 2015
  • UAB Center for AIDS Research - Biostatistics and Epidemioloogy  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2009 - 2014
  • UAB Pre and Post-Doctoral Training Program in Biostatistics  awarded by National Institute of Neurological Disorders and Stroke/NIH/DHHS 2007 - 2013
  • Phase II Trial of Sildenafil in Newborns with Persistent Pulmonary Hypertension  awarded by University of Colorado 2010 - 2012
  • Non-Invasive Inhaled Nitric Oxide in Premature Newborns  awarded by University of Colorado 2008 - 2012
  • Thymectomy in Non-Thymomatous MG Patients on Prednisone  awarded by National Institute of Neurological Disorders and Stroke/NIH/DHHS 2005 - 2012
  • Effect of Single vs. Combination Therapy on Contrast Letter Acuity in MS Patients  awarded by National Multiple Sclerosis Society 2006 - 2010
  • Mechanisms of Neurodegeneration and Strategies for Neuroprotection in MS  awarded by Johns Hopkins University 2005 - 2010
  • Investigator On

  • Investigating the Impact of Cognition on Capacity in Multiple Sclerosis  awarded by National Institute of Child Health and Human Development/NIH/DHHS 2018 - 2023
  • Therapeutic Targeting of the Myofibroblast in Fibrotic Lung Disease  awarded by National Heart, Lung, and Blood Institute/NIH/DHHS 2018 - 2023
  • Therapeutic Targeting of the Myofibroblast in Fibrotic Lung Disease - Project One: A Phase IIB Clinical Trial of the Safety and Efficacy of a NOX1/4 Inhibitor in IPF  awarded by National Heart, Lung, and Blood Institute/NIH/DHHS 2018 - 2023
  • UAB-UCSD O'Brien Center for Acute Kidney Injury Research  awarded by National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS 2018 - 2023
  • UAB-UCSD O'Brien Center for Acute Kidney Injury Research - Admin Core  awarded by National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS 2018 - 2023
  • Treadmill Walking Exercise Training Effects on Cognition and Brain Function in Multiple Sclerosis: A Systematically-Developed Randomized Controlled Trial  awarded by National Institute of Child Health and Human Development/NIH/DHHS 2018 - 2023
  • The Exercise and Physical Activity Collaborative Team (ExPact): A Proposed MoTrPAC Clinical Center  awarded by National Institute of Arthritis & Musculoskeletal & Skin Diseases/NIH/DHHS 2016 - 2022
  • Autoantibody-Targeted Therapy for Acute Exacerbations of Idiopathic Pulmonary Fibrosis  awarded by National Heart, Lung, and Blood Institute/NIH/DHHS 2017 - 2022
  • ACES - ACE Inhibitors Combined with Exercise for Hypertensive Seniors  awarded by National Institute on Aging/NIH/DHHS 2017 - 2022
  • Private Grant  awarded by BOSTON SCIENTIFIC CORPORATION 2017 - 2022
  • In Silico Screening of Medications for Slowing Alzheimer's Disease Progression  awarded by National Institute on Aging/NIH/DHHS 2017 - 2022
  • Integrating Novel Mechanisms Controlling Sodium Excretion and Blood Pressure  awarded by National Heart, Lung, and Blood Institute/NIH/DHHS 2017 - 2022
  • Integrating Novel Mechanisms Controlling Sodium Excretion and Blood Pressure - Admin Core  awarded by National Heart, Lung, and Blood Institute/NIH/DHHS 2017 - 2022
  • Noninvasive Biomarkers to Advance Emerging DBS Electrode Technologies in Parkinson’s Disease  awarded by National Institute of Neurological Disorders and Stroke/NIH/DHHS 2016 - 2022
  • Comparative Effectiveness of an Exercise Intervention Delivered via Telerehabilitation and Conventional Mode of Delivery  awarded by SHEPHERD CENTER 2018 - 2022
  • Private Grant  awarded by MEREO BIOPHARMA 4 LIMITED 2017 - 2021
  • Oncolytic Immunotherapy Using Chimeric HSV C134: A Phase I Trial and Establishment of Response Indicators in Recurrent Glioma Patients  awarded by National Cancer Institute/NIH/DHHS 2018 - 2021
  • Improving Cognition In People With Progressive Multiple Sclerosis: A Multi-Arm, Randomized, Blinded, Sham-Controlled Trial Of Cognitive Rehabilitation And Aerobic Exercise  awarded by MULTIPLE SCLEROSIS SCIENTIFIC RESEARCH FOUNDATION CANADA 2018 - 2021
  • Preventing Epilepsy using Vigabatrin in Infants with Tuberous Sclerosis Complex  awarded by National Institute of Neurological Disorders and Stroke/NIH/DHHS 2016 - 2021
  • Private Grant  awarded by HORIZON PHARMA USA, INC. 2017 - 2020
  • Targeted Clinical Research to Address Select Viral Infections-A Phase II Randomized Six Weeks of Oral Valganciclovir Therapy in CMV Infants with Hearing Loss  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2011 - 2020
  • Structural and Neurometabolic White Matter Integrity in the Deficit Syndrome  awarded by National Institute of Mental Health/NIH/DHHS 2015 - 2020
  • Targeted Clinical Research to Address Select Viral Infections-An Adaptive, Sequential Study Evaluation Prevention of Neonatal Herpes Simplex Virus Disease: Detection of Maternal Herpes Simplex Virus Shedding at Delivery  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2011 - 2020
  • Targeted Clinical Research to Address Select Viral Infections-Pharmacokinetic, Pharmacodynamic and Resistance Evaluation of Intravenous Ganciclovir in Premature Infants  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2011 - 2020
  • Targeted Clinical Research to Address Select Viral Infections-Safety, Tolerability and Pharmacokinetic Properties of CMX001 in Renal Transplant Recipients with BK Viremia.  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2011 - 2020
  • Project BIPAMS: Behavioral Intervention for Physical Activity in MS  awarded by National Multiple Sclerosis Society 2017 - 2020
  • Effect of Pitavastatin on Kidney Function in HIV-infected Persons  awarded by National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS 2015 - 2020
  • National Resource Center for High-Impact Clinical Trials in Medical Rehabilitation: Admin Oversight Component  awarded by National Institute of Child Health and Human Development/NIH/DHHS 2015 - 2020
  • National Resource Center for High-Impact Clinical Trials in Medical Rehabilitation: Coordinating Center  awarded by National Institute of Child Health and Human Development/NIH/DHHS 2015 - 2020
  • National Resource Center for High-Impact Clinical Trials in Medical Rehabilitation: Pilot Projects Component  awarded by National Institute of Child Health and Human Development/NIH/DHHS 2015 - 2020
  • Rehabilitation Research Resource to Enhance Clinical Trials (REACT)  awarded by National Institute of Child Health and Human Development/NIH/DHHS 2015 - 2020
  • A Phase 1 Study of M032, a Genetically Engineered HSV-1 Expressing IL-12, in Patients with Recurrent/Progressive Glioblastoma Multiforme, Anaplastic Astrocytoma, or Gliosarcoma  awarded by National Cancer Institute/NIH/DHHS 2017 - 2020
  • Changes in Visual Cortical Connectivity Following Central Visual Field Loss  awarded by National Eye Institute/NIH/DHHS 2016 - 2020
  • Vascular Effects of Mineralocorticoid Receptor Antagonism in Kidney Disease  awarded by National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS 2015 - 2020
  • REduCing Immunogenicity to PegloticasE (RECIPE)  awarded by National Institute of Arthritis & Musculoskeletal & Skin Diseases/NIH/DHHS 2018 - 2020
  • Resveratrol and Exercise to Treat Functional Limitations in Late Life  awarded by National Institute on Aging/NIH/DHHS 2018 - 2020
  • UAB Center for Clinical and Translational Science (CCTS) (3 Linked Awards UL1, KL2, TL1)  awarded by National Center for Advancing Translational Sciences/NIH/DHHS 2015 - 2020
  • Chronobiology and Chronopharmacology to Prevent Sickle Cell Nephropathy  awarded by National Heart, Lung, and Blood Institute/NIH/DHHS 2015 - 2020
  • Glutamate, Brain Connectivity and Duration of Untreated Psychosis  awarded by National Institute of Mental Health/NIH/DHHS 2014 - 2020
  • Unlocking Dystonia from Parkinson's Disease with Directional DBS Technology  awarded by Fox (Michael J.) Foundation for Parkinson's Research 2018 - 2020
  • Decisional Capacity Evaluation in Metastatic Brain Cancer  awarded by American Cancer Society, Inc. 2015 - 2019
  • Lipoic Acid for the Treatment of Progressive Multiple Sclerosis  awarded by Oregon Health & Science University 2017 - 2019
  • UAB Cannabidiol Program  awarded by ALABAMA DEPARTMENT OF COMMERCE 2014 - 2019
  • Targeted Clinical Research to Address Select Viral Infections-An Adaptive Pharmacokinetic, Pharmacodynamic, Concentration Response Investigation of CMX-001 in the Infants with Neonatal Herpes (HSV) Followed by Randomized Assessment  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2011 - 2019
  • AZD9688: A First in Class Disease Modifying Therapy to Treat Alpha-1 Antitrypsin Deficiency a Genetically Linked Orphan Disease  awarded by National Center for Advancing Translational Sciences/NIH/DHHS 2018 - 2019
  • Early Biomarkers of Autism Spectrum Disorders in Infants with Tuberous Sclerosis Complex (Fixed Costs)  awarded by CHILDREN'S HOSPITAL (BOSTON) 2012 - 2019
  • A Pilot Study for Testing the Feasibility and Efficacy of Text Messaging and Newsletter as a Strategy for Interrupting Sedentary Behavior  awarded by CONSORTIUM OF MULTIPLE SCLEROSIS CENTERS 2018 - 2019
  • Diagnosis of Parkinson's Disease Using Diffusion Tensor Imaging  awarded by National Institute of Neurological Disorders and Stroke/NIH/DHHS 2014 - 2019
  • The UAB Sexually Transmitted Infections Cooperative Research Centers (STI CRC)  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2014 - 2019
  • UAB Center for AIDS Research  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2014 - 2019
  • Private Grant  awarded by EXELIXIS, INC. 2014 - 2019
  • Neurofibromatosis Clinical Consortium Award  awarded by DOD - ARMY MEDICAL RESEARCH ACQUISITION ACTIVITY 2012 - 2019
  • Premature Infants Receiving Milking or Delayed Cord Clamping: Randomized Controlled Multicenter Non-Inferiority Trial (PREMOD2)  awarded by SHARP HEALTHCARE FOUNDATION 2017 - 2019
  • Pilot and Feasibility Trial of a Telehealth Dietary Intervention for MS  awarded by National Multiple Sclerosis Society 2017 - 2019
  • Private Grant  awarded by GW RESEARCH LTD. 2014 - 2018
  • Private Grant  awarded by GW RESEARCH LTD. 2014 - 2018
  • Autophagy-Lysosome Pathway Function in HIV: Effects of Antiretroviral Therapy and Relevance to Neurocognitive Status  awarded by Brigham and Women's Hospital 2017 - 2018
  • Harnessing Neuroplasticity to Promote Rehabilitation: CI Therapy for TBI  awarded by DOD - ARMY MEDICAL RESEARCH ACQUISITION ACTIVITY 2014 - 2018
  • 14-3-3 Phosphorylation as a Biomarker for Parkinson's Disease  awarded by Fox (Michael J.) Foundation for Parkinson's Research 2015 - 2018
  • UAB/UCSD O'Brien Core Center for Acute Kidney Injury Research  awarded by National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS 2013 - 2018
  • UAB/UCSD O'Brien Core Center for Acute Kidney Injury Research - Administrative Core  awarded by National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS 2013 - 2018
  • Private Grant  awarded by Pfizer Inc., U.S. Pharmaceuticals Group 2013 - 2018
  • A Home-Based Couples Intervention to Enhance PMTCT and Family Health in Kenya  awarded by National Institute of Mental Health/NIH/DHHS 2014 - 2018
  • A Phase II Study of Everolimus (RAD001) for Children with Neurofibromatosis Type I and Chemotherapy-Refractory Radiographic Progressive Low-Grade  awarded by Children's Tumor Foundation 2013 - 2018
  • The Effect of Low Frequency STN DBS on Sleep and Vigilance in PD Patients  awarded by National Institute of Neurological Disorders and Stroke/NIH/DHHS 2012 - 2017
  • Functional Change in Mild Cognitive Impairment  awarded by National Institute on Aging/NIH/DHHS 2010 - 2017
  • UAB Biostatistics Pre-Doctoral Training Program  awarded by National Heart, Lung, and Blood Institute/NIH/DHHS 2010 - 2017
  • Private Grant  awarded by MEDTRONIC, INC. 2015 - 2017
  • ChLorthalidone in Chronic Kidney Disease (CLICK) Study  awarded by Indiana University 2015 - 2016
  • Effectiveness of DiscontinuinG BisphosphonatEs Study (EDGE)  awarded by National Institute of Arthritis & Musculoskeletal & Skin Diseases/NIH/DHHS 2013 - 2016
  • Private Grant  awarded by CREALTA PHARMACEUTICALS, LLC - NEW 2015 - 2016
  • Early Warning Signs of Impaired Financial Skills in Older Adults  awarded by National Endowment for Financial Education 2013 - 2015
  • 14-3-3 Phosphorylation as a Biomarker for Parkinson's Disease  awarded by Fox (Michael J.) Foundation for Parkinson's Research 2014 - 2015
  • Population Genetics Analysis Program: Immunity to Vaccines/Infections II  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2012 - 2015
  • Cesarean Section Optimal Antibiotic Prophylaxis (C/SOAP) Trial  awarded by National Institute of Child Health and Human Development/NIH/DHHS 2010 - 2015
  • Epidemiology of Dental Caries and Immunity in Children  awarded by National Institute of Dental and Craniofacial Research/NIH/DHHS 2011 - 2015
  • Innate Immunity and Viral Renal Allograft Injury  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2013 - 2015
  • Private Grant  awarded by Pfizer Pharmaceuticals 2010 - 2014
  • Rehabilitating Extremity Use after Multiple Sclerosis  awarded by National Multiple Sclerosis Society 2009 - 2014
  • UAB-UCSD O'Brien Core Center for Acute Kidney Injury Research  awarded by National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS 2008 - 2014
  • UAB-UCSD O'Brien Core Center for Acute Kidney Injury Research - Administrative Core  awarded by National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS 2008 - 2014
  • TSC Autism Center of Excellence Research Network (TACERN) Research  awarded by CHILDREN'S HOSPITAL (BOSTON) 2012 - 2014
  • UAB Center for AIDS Research  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2009 - 2014
  • UAB Center for Clinical and Translational Science (CCTS) UL1  awarded by National Center for Advancing Translational Sciences/NIH/DHHS 2011 - 2014
  • Early Biomarkers of Autism Spectrum Disorders in Infants with Tuberous Sclerosis  awarded by CHILDREN'S HOSPITAL (BOSTON) 2012 - 2013
  • Liposomal Recombinant Vaccine and Caries Immunity  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2006 - 2013
  • Center for Pediatric-Onset Demyelinating Disease  awarded by National Multiple Sclerosis Society 2006 - 2013
  • Design Issues in Obesity RCTs: Building an Evidence Base  awarded by National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS 2009 - 2013
  • Exploring the Effects of Rehabilitation on Brain Remodeling in Progressive MS  awarded by National Institute of Child Health and Human Development/NIH/DHHS 2009 - 2012
  • Teaching Activities

  • BST698 - Non Thesis Research (Spring Term 2018) 2018
  • BST799 - Dissertation Research (Fall Term 2017) 2017
  • BST625 - Design/Conduct Clinical Trials (Summer Term 2017) 2017
  • BST698 - Non Thesis Research (Summer Term 2017) 2017
  • BST799 - Dissertation Research (Summer Term 2017) 2017
  • BST698 - Non Thesis Research (Spring Term 2017) 2017
  • BST799 - Dissertation Research (Spring Term 2017) 2017
  • BST698 - Non Thesis Research (Fall Term 2016) 2016
  • BST799 - Dissertation Research (Fall Term 2016) 2016
  • BST625 - Design/Conduct Clinical Trials (Summer Term 2016) 2016
  • BST799 - Dissertation Research (Summer Term 2016) 2016
  • BST698 - Non Thesis Research (Spring Term 2016) 2016
  • BST799 - Dissertation Research (Spring Term 2016) 2016
  • BST698 - Non Thesis Research (Fall Term 2015) 2015
  • BST799 - Dissertation Research (Fall Term 2015) 2015
  • BST798 - Non-Dissertation Research (Summer Term 2015) 2015
  • BST698 - Non Thesis Research (Spring Term 2015) 2015
  • BST798 - Non-Dissertation Research (Spring Term 2015) 2015
  • BST799 - Dissertation Research (Spring Term 2015) 2015
  • BST695 - Special Topics (Fall Term 2014) 2014
  • BST798 - Non-Dissertation Research (Fall Term 2014) 2014
  • BST799 - Dissertation Research (Fall Term 2014) 2014
  • BST625 - Design/Conduct Clinical Trials (Summer Term 2014) 2014
  • BST798 - Non-Dissertation Research (Summer Term 2014) 2014
  • BST799 - Dissertation Research (Summer Term 2014) 2014
  • BST798 - Non-Dissertation Research (Spring Term 2014) 2014
  • BST799 - Dissertation Research (Spring Term 2014) 2014
  • BST698 - Non Thesis Research (Fall Term 2013) 2013
  • BST798 - Non-Dissertation Research (Fall Term 2013) 2013
  • BST799 - Dissertation Research (Fall Term 2013) 2013
  • BST625 - Design/Conduct Clinical Trials (Summer Term 2013) 2013
  • BST798 - Non-Dissertation Research (Summer Term 2013) 2013
  • BST698 - Non Thesis Research (Spring Term 2013) 2013
  • BST798 - Non-Dissertation Research (Spring Term 2013) 2013
  • BST698 - Non Thesis Research (Fall Term 2012) 2012
  • BST798 - Non-Dissertation Research (Fall Term 2012) 2012
  • BST625 - Design/Conduct Clinical Trials (Summer Term 2012) 2012
  • BST798 - Non-Dissertation Research (Summer Term 2012) 2012
  • BST698 - Non Thesis Research (Spring Term 2012) 2012
  • BST798 - Non-Dissertation Research (Spring Term 2012) 2012
  • BST625 - Design/Conduct Clinical Trials (Summer Term 2011) 2011
  • BST698 - Non Thesis Research (Summer Term 2011) 2011
  • BST698 - Non Thesis Research (Spring Term 2011) 2011
  • BST698 - Non Thesis Research (Fall Term 2010) 2010
  • BST625 - Design/Conduct Clinical Trials (Summer Term 2010) 2010
  • BST690 - Biostatic Consult and App Prob (Summer Term 2010) 2010
  • BST698 - Non Thesis Research (Summer Term 2010) 2010
  • BST697 - Internship in Biostatistics (Spring Term 2010) 2010
  • BST698 - Non Thesis Research (Spring Term 2010) 2010
  • BST625 - Design/Conduct Clinical Trials (Summer Term 2009) 2009
  • BST698 - Non Thesis Research (Summer Term 2009) 2009
  • BST798 - Non-Dissertation Research (Fall Term 2008) 2008
  • BST625 - Design/Conduct Clinical Trials (Summer Term 2008) 2008
  • BST697 - Internship in Biostatistics (Summer Term 2008) 2008
  • BST799 - Dissertation Research (Summer Term 2008) 2008
  • BST619 - Data Collection Management (Spring Term 2008) 2008
  • BST690 - Biostatistical Consulting (Spring Term 2008) 2008
  • BST698 - Non Thesis Research (Spring Term 2008) 2008
  • BST799 - Dissertation Research (Spring Term 2008) 2008
  • BST698 - Non Thesis Research (Fall Term 2007) 2007
  • BST798 - Non-Dissertation Research (Fall Term 2007) 2007
  • BST799 - Dissertation Research (Fall Term 2007) 2007
  • Education And Training

  • Doctor of Philosophy in Biometrics, University of Texas System : Health Science Center-Houston 1974
  • Full Name

  • Gary Cutter